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ABSTRACT
Background: The world population is aging rapidly. This growth of the aging population 
is accompanied by an increased number of frail elderly people who are at risk of adverse 
health outcomes such as disability, co-morbidity and mortality. A dominant feature of frailty 
is the age-related loss of muscle mass, strength and performance, also called sarcopenia. 
Resistance-type exercise training and dietary protein supplementation are considered 
promising strategies to reverse sarcopenia and subsequent frailty. However, strong evidence 
for the impact of protein supplementation with or without resistance exercise in frail elderly 
people is scarce. Well-designed intervention studies in frail elderly people are needed to 
define new leads for the development of nutritional and exercise interventions to effectively 
prevent or treat the progressive loss of muscle mass, strength and physical performance with 
aging. Therefore, the aims of this thesis are to study 1) the impact of protein supplementation 
and 2) the impact of protein supplementation during prolonged resistance-type exercise 
training on muscle mass, strength and physical performance in frail elderly people.
Methods: First, we studied various characteristics of dietary protein intake, including the 
distribution of dietary protein intake throughout the day, and the use of protein-containing 
food sources in various elderly populations. With this knowledge, we designed two large 
intervention trials to study the impact of dietary protein supplementation with or with-
out prolonged resistance-type exercise training on muscle mass, strength and physical 
performance in frail elderly people. In addition, we assessed the usefulness of handgrip 
strength as a measure of post exercise strength differences and studied the association of 
vitamin D status and vitamin D intake on muscle mass, strength and physical performance 
in a frail elderly population.
Results: Dietary protein intake in frail and institutionalized elderly people were especially 
low at breakfast and lunch. Supplementing protein at breakfast and lunch did not increase 
muscle mass but improved physical performance in frail elderly people. Resistance-type 
exercise training improved muscle leg strength and physical performance, but not handgrip 
strength. Supplementing protein at breakfast and lunch was required to significantly 
increase muscle mass during prolonged resistance-type exercise training in frail elderly 
people. Furthermore, low vitamin D status and vitamin D intake were associated with 
impaired physical performance.
Conclusions: Although dietary protein supplementation does not increase muscle mass, 
it represents a promising strategy to improve physical performance in frail elderly people. 
Prolonged resistance-type exercise training represents an effective strategy to improve 
strength and physical performance, but dietary protein supplementation is required to 
allow muscle mass gain during exercise training in frail elderly people.
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Aging 
The world population is aging rapidly. Since 1980, the number of people aged 60 y and 
over has doubled to approximately 810 million. The elderly population will continue 
to grow to approximately 2 billion in 2050. It has been predicted that 22% of the total 
population will be older than 60 y and 4.4% will be older than 80 y in 20501. In the 
Netherlands, the rise in the aging population will be even more pronounced as the 
number elderly people above 65 y will grow to 4.4 million or 25% of the total population 
in 20602. This immense growth of the aging population is due to the post-world war 
II baby boom as well as the higher life expectancy for males and females. In 2060, it is 
expected that life expectancy will be 84.5 y for males and 87.4 y for females. This higher 
life expectancy is mainly attributed to education, hygiene, less environmental threats 
and better healthcare3.
As society ages, the incidence of physical disability will increase as well. Approximately 
30% of the population 55 y and older are confronted with moderate or severe physical 
disabilities4. This physical disability decreases quality of life, increases the risk of 
institutionalization and hospitalization and even of premature death5. In addition, the 
higher age-related prevalence of physical disability will increase the demand on our 
health care system. Prevention of disability or even treatment for disability is therefore 
relevant for public health. The Dutch Ministry of Health, Welfare and Sport emphasizes 
the importance of prevention and treatment of disability in order to age healthy and stay 
physically active and independent as long as possible2.
Frailty
Frailty is a relatively new concept that is described as a geriatric syndrome of decreased 
reserves and resistance to stressors, which increases the risk of adverse outcomes such as 
the onset of disability, institutionalization and premature death6,7. The prevalence of frailty 
increases with age. A recent systematic review of 21 community-based studies involving 
61500 elderly people reported a prevalence of frailty between 4–59%8. On average, 10.7% 
of the community-dwelling older persons are frail and 41.6% are pre-frail. After the age of 
85 y, the average prevalence of community-based frailty increases enormously to almost 
26.1%8. In the latter age category, the prevalence of frailty is even more pronounced in 
institutionalized elderly and is estimated to be 40%9. The reported prevalences differ 
substantially which is attributed to the definition of frailty used. The majority of definitions 
of frailty used are based upon physical function. The most commonly used frailty criteria 
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are those of Fried et al.10. These include unintentional weight loss, weakness, self-reported 
exhaustion, slow walking speed, and low physical activity. Subjects with one or two 
criteria present are defined as pre-frail and subjects with three or more criteria present 
are defined as frail10. It has been suggested, however, that frailty is much more broader 
than the physical criteria and should also include cognitive status, mood, social resources, 
number of comorbidities and nutritional status6,11-13. This multidimensional nature of frailty 
might be the cause of no uniformly and broadly accepted definition of frailty. Despite 
no clear consensus, more researchers acknowledge frailty as one of the most important 
geriatric conditions. Frailty has been described as a reversible condition11 and therefore 
efficacious interventions need to be developed and tested to prevent pre-frailty and/or 
even reverse the frailty state.
Sarcopenia
An important determinant of frailty is the age-related loss of muscle mass, strength and 
performance also referred to as sarcopenia. The term sarcopenia was first introduced in 
the late eighties by Rosenberg and stems from the Greek. It literally means poverty (penia) 
of flesh (sarc)14. As the term sarcopenia reflects, muscle mass changes throughout the 
lifespan (Figure 1.1). From birth, the amount of muscle mass increases rapidly. At the age 
of approximately 35 y, muscle mass and strength start to decline15-19. A recent quantitative 
review showed that the median decline in muscle mass throughout the lifespan is 0.37% 
per year in women and 0.47% per year in men20. According to longitudinal studies in 
Figure 1.1 Changes of muscle mass and strength throughout the lifespan. Adapted from 
Sayer et al.17.
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people aged 75 y or over20, muscle mass is lost at a rate of 0.64–0.70% per year in women 
and 0.80–0.98% per year in men. Strength is lost more rapidly. At the age of 75 y, strength 
is lost at a rate of 3–4% per year in men and 2.5–3% per year in women20.
Baumgartner et al. operationalized sarcopenia as the amount of appendicular lean 
mass (sum of lean mass tissue of arms and legs) 2 SDs lower than the gender specific 
mean of appendicular lean mass of a young and healthy population21. Later Janssen et 
al. operationalized sarcopenia with a classification of severity22. Class 1 sarcopenia was 
considered present when the muscle mass index (total muscle mass/ total body weight) 
was between 1 and 2 SDs lower than a gender specific mean of a young population. Class 
2 sarcopenia was considered present when the muscle mass index was more than 2 SDs 
lower than a gender specific mean of a young population. Subsequently, loss of muscle 
strength and physical performance became part of the definition of sarcopenia23,24. In 
2010, the latest consensus definition was presented by the European Working Group on 
Sarcopenia in Older People25. They proposed a diagnosis of sarcopenia to require low 
muscle mass accompanied by either low muscle strength or low physical performance. 
Pre-sarcopenia was defined as low muscle mass according to the Baumgartner criteria, 
sarcopenia was determined as pre-sarcopenia with either loss of strength (lowest quartile 
of handgrip strength in sample distribution), or physical performance (gait speed ≤0.8 
m/s) and severe sarcopenia was defined when all 3 aspects were present. Depending on 
the criteria, the prevalence of sarcopenia is approximately 6–24% of people above 60 y 
and increases with age to 40–50% of people above 80 y23,26,27. Although a global consensus 
definition is not yet reached, sarcopenia is now recognized as an important geriatric 
condition and represents a key factor in the development of frailty6,11,23,28-30. The progressive 
loss of skeletal muscle mass, strength, and physical performance results in an increased 
risk for adverse outcomes such as onset of disability, morbidity, institutionalization, and 
mortality6. As such, sarcopenia imposes a heavy burden on our health care system. In 
the US, the direct cost of sarcopenia in 2000 has been estimated to be 1.5% of the total 
health care cost, representing 18.5 billion dollar31. Furthermore, it should be noted that 
skeletal muscle mass is an important metabolic organ. Muscle mass is not only a major 
depot for glucose storage, it also plays an important role in glucose, fat and protein 
metabolism as well as in energy metabolism32,33. Consequently, it has been suggested 
that sarcopenia increases the risk of developing diabetes, cardiovascular diseases and 
obesity33,34. Hence, the healthcare cost related to sarcopenia is believed to be far beyond 
the previously presented 18.5 billion dollar.
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Causes of sarcopenia
The decline in skeletal muscle mass with aging is attributed to a disruption in the regulation 
of skeletal muscle protein turnover, leading to a structural imbalance between muscle 
protein synthesis and muscle protein breakdown33,35. Factors that impair muscle protein 
synthesis or factors that stimulate muscle protein breakdown are playing a key role in the 
development of sarcopenia23. In addition, skeletal muscle satellite cells (SC) have been 
suggested to be involved in the development of sarcopenia36-38 as these muscle stems cells 
are essential for muscle fiber repair, maintenance and growth. The process of sarcopenia 
occurs over a prolonged period of time and is acknowledged to be multifactorial34,39. 
The major factors considered to be involved include inflammation, hormonal changes, 
neurological factors, physical inactivity, and inadequate nutritional intake23,34.
Inflammation
Epidemiological data have shown that inflammatory cytokines such as interleukin-6 (IL-6) 
and Tumor Necrosis Factor-α (TNF-α) are elevated in elderly people40. These elevated levels 
of IL-6 of and TNF-α, also known as low-grade chronic inflammation, were associated 
with a decline in muscle mass and strength41,42. Animal studies have demonstrated that 
higher TNF-α concentrations in rats lead to significant loss of muscle mass43-45, which is 
likely to occur via the activation of the ubiquitin–proteasome pathway and apoptosis, and 
perhaps via reduced basal muscle protein synthesis rates46. In addition, it is suggested that 
TNF-α also negatively affects the muscle regenerating capacity by destabilizing MyoD 
and myogenin47. These muscle specific transcription factors are involved in the transition 
from proliferation to differentiation of satellite cells48. In elderly people, the relatively high 
levels of inflammatory cytokines over many years inhibit differentiation of satellite cells, 
and hence maintenance of the muscle, resulting in a slow but progressive loss of muscle 
mass and subsequent sarcopenia.
Hormonal changes
Aging results in a significant decline in plasma testosterone, growth hormone (GH) and 
insulin like growth factor-1 (IGF-1) concentrations49. These reduced levels have been 
associated with sarcopenia. Both testosterone and GH are powerful anabolic agents that 
promote muscle protein synthesis and subsequent muscle mass accretion24,50,51. Circulating 
IGF-1 plays an active role in regulating GH secretion through a negative feedback 
mechanism and thereby influencing muscle mass. Furthermore, IGF-1 is produced locally 
in the muscle, where it stimulates the phosphorylation of mammalian target of rapamycin 
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(mTOR), one of the key regulators of muscle protein synthesis52. Although a decline in 
hormone status may contribute to the loss of muscle mass with aging, it remains unclear 
whether this decline is inherent to changes in lifestyle associated with aging49.
Neurological factors
Age-related changes in the neuromuscular system play an important role in the onset of 
sarcopenia. The number and function of motor neurons decline with age53. These motor 
neurons are responsible for sending signals from the brain to the muscle to initiate 
movement. Motor units consist of a motor neuron and all of the muscle fibers innervated 
by that neuron. Fast twitch motor units are bigger and result in faster muscle contraction, 
producing much more force when compared to slow twitch motor units. It has been 
suggested that aging leads to accelerating denervation rates of fast twitch, large motor 
units54, explaining the loss of type II muscle fibers in elderly people55. Although the loss 
of fast twitch motor units contributes to the loss of muscle, it mainly contributes to the 
age-associated loss of muscle strength54. Interestingly, the loss of muscle strength, also 
referred to dynapenia, occurs much more rapid than the concomitant loss of muscle 
mass16. The latter suggests that intervention studies should not only target muscle mass 
but should also focus on muscle strength and physical performance.
Physical inactivity
There is ample evidence that physical inactivity has a large impact on the average life 
expectancy as well as on quality of life. In fact, physical inactivity is one of the strongest 
predictors of physical disability in elderly people56,57. Epidemiological data have shown 
that low levels of physical activity relate to an accelerated decline in muscle mass, strength 
and physical performance58-60. Indeed, physical activity is considered the main anabolic 
stimulus, responsible for stimulating muscle protein synthesis and, as such, preserving 
muscle mass as protein turns over continually61. Evidence from bed rest and/or lower limb 
immobilization studies have shown that muscle mass and performance is lost very rapidly 
after acute inactivity56,62. Kortebein et al. observed a 0.95 kg loss of lean leg mass after 
just 10 d of bed rest in healthy elderly people56. The latter muscle loss was accompanied 
with a 12% loss of muscle strength and 14% loss of physical performance. These findings 
suggest that physical inactivity plays a key role in the development of sarcopenia, frailty 
and subsequent physical disability. In turn, sarcopenia, frailty and disability decrease the 
level of physical activity and thereby maintain the negative vicious circle as depicted in 
Figure 1.263.
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Inadequate nutritional intake
The aging process is associated with a decline in appetite and food intake known as 
anorexia of aging64. The prevalence of anorexia of aging amounts to 21% in elderly above 
65 y and is more prevalent in frail and institutionalized elderly65. Anorexia and subsequent 
weight loss have been associated with adverse health outcomes such as falls, immobility 
and sarcopenia. In fact, recent epidemiological data from the ilSIRENTE study showed 
an 88% higher risk of sarcopenia in elderly suffering from anorexia compared with non-
anorexic elderly people66. Anorexia of aging is related to a decline in the intake of various 
nutrients such as dietary protein and vitamin D. These nutrients are suggested to play an 
important role in the development of sarcopenia67,68.  
Dietary protein
In the absence of dietary protein intake, i.e. during fasting conditions, muscle protein 
breakdown exceeds muscle protein synthesis which creates a negative muscle protein 
balance, and, after a prolonged period of time, results in muscle loss. Following protein 
intake, i.e. in the postprandial phase, digestion and absorption of dietary protein increase 
the availability of plasma amino acids69-71. A rapid increase in postprandial plasma amino 
acid concentrations strongly increases muscle protein synthesis rates, reduces muscle 
protein breakdown rates, resulting in a positive protein balance. However, with the 
ingestion of small, meal-like amounts of dietary protein attenuation of the postprandial 
skeletal muscle protein synthetic response concurs in elderly people72,73. Such an 
attenuated postprandial muscle protein synthetic response would result in a negative 
muscle protein balance, and subsequent loss of muscle mass. The latter anabolic resistance 
to meal-like protein intakes might become of great clinical relevance over the course 
of many years. In fact, it has been proposed that anabolic resistance represents one of 
Figure 1.2 The role of physical activity in the development of sarcopenia, frailty and disability 
and vice versa, adapted from Freiberger et al.63.
Physical activity Sarcopenia DisabilityFrailty
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the key-factors responsible in the development of sarcopenia and frailty33. To overcome 
the anabolic resistance to small protein intakes, it has been suggested that 25 to 30 g of 
dietary protein per meal is required to allow an appropriate stimulation of postprandial 
muscle protein synthesis. The suggested increase of dietary protein per meal would 
increase the daily protein intake to 1.2–1.5 g per kg bodyweight (g/kg-bw). It has been 
reported that this daily protein intake substantially attenuates muscle loss (i.e. 40%) 
when compared with a daily protein intake of 0.8 g/kg-bw, i.e., the current recommended 
dietary allowance (RDA)74. These results suggest that dietary protein supplementation 
might be a promising nutritional strategy aiming to postpone and/or treat sarcopenia 
in elderly people.
Vitamin D
Another important nutrient that might relate to sarcopenia is vitamin D. The reduction 
in endogenous vitamin D synthesis together with low vitamin D intakes result in a high 
prevalence of vitamin D deficiency among elderly people. The estimated prevalence 
of vitamin D deficiency among elderly people is between 45 and 57%75-78 and among 
compromised geriatric patients vitamin D deficiency is even more pronounced79,80. Low 
vitamin D status has been associated with poor muscle mass and impaired physical 
performance in community-dwelling elderly people81-85. Mechanistically, it is suggested 
that the activation of the vitamin D receptor (VDR) in skeletal muscle tissue plays an 
important role in muscle protein turnover86. The activation of the VDR might stimulate 
skeletal muscle protein synthesis86,87 and might prevent type II muscle fiber atrophy88. 
In addition, it has been suggested that 1,25-dihydroxycholecalciferol, the active form of 
25-hydroxyvitamin D (25(OH)D), regulates muscle calcium concentrations by modulating 
the activity of calcium pumps in sarcoplasmic reticulum and sarcolemma81. Alterations 
in intracellular calcium concentrations regulate the contraction and relaxation of the 
muscle, which may impact physical performance. Unfortunately, the role of vitamin D 
intake and vitamin D status in the development, prevention and treatment of sarcopenia 
and frailty is still unclear. 
Interventions to counteract sarcopenia
The majority of intervention studies that target sarcopenia or frailty have focused on the 
above mentioned causes of sarcopenia. The most promising lifestyle interventions that 
stimulate anabolic and/ or inhibit catabolic pathways in elderly people are exercise and 
nutritional interventions.
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Resistance-type exercise
Resistance-type exercise training is currently the most effective intervention to slow 
down the decline of muscle mass and muscle strength. Resistance-type exercise training 
involves planned, structured and repetitive small number of muscle contractions against 
heavy loads35. Whereas endurance-type exercise training mainly increases oxidative 
capacity89, resistance-type exercise training enhances muscle mass and strength in healthy 
and frail elderly people90-93. A single session of resistance-type exercise increases both 
muscle protein synthesis and breakdown rates, albeit the latter to a lesser extent61,94. 
This results in an increased muscle net muscle protein balance that persists up to 48h 
in the young61. In the absence of food intake, however, the net muscle protein balance 
remains negative and muscle hypertrophy cannot occur. Furthermore, ample studies show 
that resistance-type exercise training improves functional outcomes such as balance, 
gait speed, chair rise and stair climbing power92,95-97. The aforementioned benefits are 
party due to an increase in the amount of contractile protein and the improvements in 
neural function98-100. 
Protein intake
It has been well-established that dietary protein ingestion stimulates skeletal muscle 
protein synthesis69,94,101-103, and inhibits protein breakdown, resulting in a more positive 
muscle protein balance94,103. So far, evidence from long-term intervention studies showed 
no clear benefit of dietary protein supplementation on skeletal muscle mass in elderly 
people. Whereas some reveal an increase in skeletal muscle mass104,105, others have 
failed to report any measurable impact of long-term dietary protein supplementation 
on skeletal muscle mass in elderly subjects106-112. This apparent discrepancy might be 
attributed to the selection of healthy versus more frail elderly subjects. Most studies 
investigating the impact of long-term protein supplementation have generally included 
healthy elderly people106,109-112. Long-term intervention studies investigating the efficacy 
of protein supplementation on skeletal muscle mass in frail elderly people, however, are 
scarce and show discrepant findings104,107,108. More research is warranted to investigate the 
impact of protein supplementation on skeletal muscle mass and physical performance 
in a frail elderly population. The latter research might provide evidence that protein 
supplementation is a promising nutritional strategy to prevent or even counteract 
sarcopenia and frailty23,113.
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Resistance-type exercise and protein intake
As mentioned previously, exercise improves muscle protein balance, but the net muscle 
protein balance will remain negative in the absence of food intake. Protein ingestion prior 
to or after exercise is required to further augment post-exercise muscle protein synthesis 
rates and inhibit protein breakdown70,94,114,115, resulting in a positive protein balance and, 
as such, net muscle protein accretion116-119. Consequently, it has been proposed that 
dietary protein supplementation is required to maximize skeletal muscle mass gain during 
prolonged resistance-type exercise training and, as such, to more effectively counteract 
sarcopenia and frailty23,113. Indeed, a recent meta-analysis reported beneficial effects of 
protein supplementation during long-term resistance-type exercise training on muscle 
mass and strength in healthy elderly people120. In contrast, studies investigating the 
impact of protein supplementation during prolonged exercise intervention in frail elderly 
are scarce and report discrepant findings107,108,121. Although protein supplementation and 
resistance-type exercise training might be very promising strategies to attenuate or even 
reverse sarcopenia, in frail elderly people more research is warranted.
Rationale and outline of thesis
In summary, the growth of the aging population has increased the focus on the importance 
of maintaining independent, and delaying frailty and subsequent disability. A major cause 
of frailty and disability is sarcopenia. The cause of sarcopenia is multi-factorial and includes 
a sedentary lifestyle and inadequate protein intake. Resistance-type exercise training and 
dietary protein supplementation might be promising strategies to reverse the age-related 
loss of muscle mass, strength and performance and subsequent frailty. However, strong 
evidence of the impact of protein supplementation with or without resistance exercise in 
frail elderly people is scarce. Well-designed human randomized double-blind placebo-
controlled intervention trials are needed to define new leads for the development of 
nutritional and exercise interventions in order to prevent or treat the progressive loss of 
muscle mass, strength and physical performance with aging. Therefore, the aims of this 
thesis are 1) to study the impact of protein supplementation on muscle mass, strength 
and physical performance in frail elderly people and 2) to study the impact of protein 
supplementation during prolonged resistance-type exercise training on muscle mass, 
strength and physical performance in frail elderly people.
To answer these research questions, we performed a set of studies that are described below. 
We started to study the protein intakes of community-dwelling, frail, and institutionalized 
elderly people (chapter 2). In this study, we assessed daily protein intake, distribution of 
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protein intake throughout the day, and the use of protein-containing food sources. With 
this knowledge, we designed intervention trials aiming to study the impact of protein 
supplementation on muscle mass, strength and physical performance in frail elderly people 
in the absence (chapter 3) or presence of a resistance-type exercise training program 
(chapter 4). Furthermore, we assessed the usefulness of handgrip strength as a measure 
for post exercise strength differences (chapter 5). Chapter 6 presents the association of 
25(OH)D status and vitamin D intake with muscle mass, strength and physical performance 
in a frail elderly population. And finally, in chapter 7, we discuss the main findings of the 
studies and provide general conclusions and directions for future research. 
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Abstract 
Purpose: Adequate dietary protein intake is required to postpone and treat sarcopenia 
in elderly people. Insight in dietary protein intake in this heterogeneous population 
segment is needed to locate dietary inadequacies and to identify target populations 
and feeding strategies for dietary interventions. Therefore, we assessed dietary protein 
intake, distribution of protein intake throughout the day, and the use of protein containing 
food sources in community-dwelling, frail, and institutionalized elderly people in the 
Netherlands. 
Methods: Secondary analyses were carried out, using dietary data collected from studies 
among community-dwelling, frail, and institutionalized elderly people, to evaluate protein 
intake characteristics. 
Results: Dietary protein intake averaged 1.1±0.3 g/kg-bw/d in community-dwelling, 
1.0±0.3 g/kg-bw/d in frail, and 0.8±0.3 g/kg-bw/d in institutionalized elderly men. Similar 
protein intakes were found in women. Ten percent of the community-dwelling and frail 
elderly and 35% of the institutionalized elderly people showed a protein intake below 
the estimated average requirement (0.7 g/kg-bw/d). Protein intake was particularly low 
at breakfast in community-dwelling (10±10 g), frail (8±5 g), and institutionalized elderly 
people (12±6 g) with bread and dairy products as predominant protein sources. 
Conclusions: Whereas daily protein intake is generally well above the recommended 
dietary allowance in community-dwelling and frail elderly people, a significant proportion 
of institutionalized elderly showed an intake below the current protein requirement, 
making them an important target population for dietary interventions. Particularly at 
breakfast, there is scope for improving protein intake. 
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Introduction 
Sarcopenia, the age-related loss of skeletal muscle mass and strength, is accompanied 
by a decline in functional ability that affects many aspects of life1. Sarcopenia is a 
process caused by a combination of factors, which include a sedentary lifestyle and an 
inadequate dietary protein intake2,3. In both young and elderly people, dietary protein 
intake stimulates skeletal muscle protein synthesis and inhibits protein breakdown, 
resulting in a positive protein balance4-6 and net muscle protein accretion7,8. Although 
results of acute studies show anabolic properties of dietary protein, so far, most dietary 
intervention studies that supplemented dietary protein for several months have failed 
to observe measurable gains in skeletal muscle mass in elderly people9-13. The absence 
of any apparent benefits of long-term protein supplementation might be attributed 
to a less than optimal feeding regimen. Various dietary protein intake strategies have 
been proposed. It has been suggested that the total amount of protein ingested is of 
importance to maintain skeletal muscle mass in elderly people. It has been reported 
that elderly people lose substantially less lean and appendicular lean body mass 
over time when consuming 1.2 g dietary protein per kg bodyweight per day (g/kg-
bw/d) when compared with a dietary protein intake of 0.8 g/kg-bw/d, i.e. the current 
recommended dietary allowance (RDA)14. Besides the importance of total daily protein 
intake, the amount of protein ingested at each meal is of relevance15. Previous studies 
show similar post-prandial skeletal muscle protein synthetic responses between young 
and older individuals after ingesting a large bolus of dietary protein16. Smaller amounts 
of dietary protein, however, have revealed an attenuated post-prandial skeletal muscle 
protein synthetic response in elderly people when compared with young individuals17,18. 
In addition, it has been suggested that protein intake distribution throughout the day 
might be of importance for daily net protein balance. For example, Arnal and co-workers 
suggested that feeding dietary protein in pulses improves nitrogen balance more than 
feeding dietary protein spread over a variety of small meals throughout the day does19. 
Finally, evidence has emerged to suggest that the type, i.e. source, of protein consumed 
may modulate the skeletal muscle anabolic response to food intake20-22. Besides the 
fact that daily amount, distribution and/or source of dietary protein in nutritional 
intervention trials might not have been optimal to observe measurable gains in skeletal 
muscle mass in healthy elderly people, it has been suggested that the proposed positive 
effects of prolonged dietary protein supplementation are confined to specific elderly 
subpopulations, e.g. frail or institutionalized elderly people13. Unfortunately, detailed 
dietary protein intake characteristics among various elderly subpopulations are still 
lacking. Insight in these dietary protein characteristics is important to locate dietary 
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protein inadequacies in this heterogeneous population segment and, as such, to define 
more effective countermeasures.
The present study was performed to assess daily protein intake, protein intake 
distribution, and the specific protein sources that are consumed in community-dwelling, 
frail, and institutionalized elderly people in the Netherlands. This study aims to locate 
dietary protein inadequacies and to identify target populations and feeding strategies 
needed to define more effective dietary interventions to postpone and treat sarcopenia 
in elderly people.
Methods
Data collection
We used data from four previously performed studies among community-dwelling, frail, 
and institutionalized elderly people. Data of apparently healthy community-dwelling 
elderly people were derived from the most recent Dutch National Food Consumption 
Survey (DNFCS) conducted in 199823. A total of 707 elderly men and women, who 
lived independently, were stratified into two age groups: 65–74 y and 75–97 y. Dietary 
intake data were randomly collected during the wk using 2-d food records. Data of frail 
independently living elderly people (n=194) came from baseline data of a randomized 
placebo-controlled trial, conducted in 1997, aiming to improve physical and mental 
health24,25. Criteria for frailty in this study were: age ≥70 y, requiring healthcare, physical 
inactivity and self-reported body mass index (BMI) of ≤25 kg/m2 or recent involuntary 
weight loss. Dietary intake data were obtained by trained dieticians using 3-d food 
records collected on two non-consecutive weekdays and one weekend day. Data of 
the institutionalized elderly people were derived from baseline dietary assessments 
of two intervention studies. The first study, INST-1 (n=60), investigated the effect of 
supplementation on nutritional status and physical performance26. The second study, INST-
2 (n=216), was designed to investigate the effect of ambiance during mealtimes in Dutch 
nursing homes27. The latter study selected elderly people who were housed in somatic 
wards. Dietary intake data were collected using 2-d food records in the INST-1 study and 
3-d food records in the INST-2 study. In addition, subject characteristics including age, 
sex, physical activity, ADL performance, cognitive function, body weight, and BMI were 
used if available. Physical activity in the frail elderly population was measured using the 
validated Physical Activity Scale for Elderly (PASE)28. The PASE, with a score ranging from 0 
to 400, is designed to assess activities commonly engaged by elderly people. In the elderly 
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people of the INST-1 study, the activities of daily living (ADL) were analyzed according to 
the Barthel index29. The Barthel index is developed to measure the performance of ADL 
and uses a scale from 0 to 100. A higher score indicates better functional capacity. In 
addition, cognitive function was measured in the INST-1 study using the Dutch revision 
of the Alzheimer’s Disease Assessment Scale (ADAS). ADAS consists of a non-cognitive 
part and a cognitive part. The latter part is used in this study and referred to as ADAS-cog, 
consisting of 12 items with a total score ranging from 0 (no impairment) to 75 (severe 
impairment)30,31. Furthermore, Mini-Mental State Examination (MMSE) scores (0–30) were 
re-analyzed in INST-1 study32.
Calculation of dietary protein intake 
Dietary intake data were coded (food intake, amount, and mealtime) and cross-checked 
by dieticians. Portion sizes were documented in household measures, whereby frequently 
used household measures were checked in all the studies. Energy and protein intakes 
were calculated with a computerized Dutch food consumption table. The DNFCS and the 
INST-1 study used the Dutch food composition table of 1996 and the FRAIL and INST-2 
study used the Dutch food composition tables of 1997 and 2001. Dietary protein intake 
was calculated as: 1) total protein intake (g/d), 2) protein intake per kilogram body weight 
(g/kg-bw/d) and 3) percentage of energy from protein (en%). Furthermore, protein intakes 
(g) per mealtime moment, i.e. breakfast, lunch, dinner, and between meals (snacks) were 
calculated and protein intake from specific food sources was assessed. Percentage of 
inadequate dietary protein intake in the community-dwelling, frail, and institutionalized 
elderly people was estimated using the cut point method33 based on the protein estimated 
average requirement (EAR) of 0.7 g/kg-bw/d.
Statistical analysis
Data analyses were performed using the SPSS statistical software package (version 
15.0). Descriptives were used to derive the mean and standard deviations of baseline 
characteristics. One-way ANOVA was used to compare differences in energy and protein 
intake between community-dwelling, frail, and institutionalized elderly people. In case of 
a significant difference (P<0.05) in energy and protein intake, Bonferroni’s post-hoc test 
was applied to locate these differences.
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Results
Characteristics of the participants
Descriptive characteristics of the study populations are presented in Table 2.1. In the 
community-dwelling, frail, and institutionalized elderly groups, the majority were women 
(58–75%). According to the PASE, low average physical activity levels were found in frail 
men (65±39) and women (63±30). The Barthel index score was 71±26 for both men and 
women in the institutionalized elderly people (INST-1) reflecting a reasonable level of 
independency in activities of daily living. Average ADAS-cog score was 18±12 and average 
MMSE score was 21±6 in institutionalized elderly people (INST-1).
Dietary intake
Lowest energy intakes were reported in institutionalized elderly people (5.8±1.5 to 8.2±1.6 
MJ/d in men; 5.9±1.6 to 6.2±1.5 MJ/d in women) whereas community-dwelling elderly 
people showed the highest energy intakes (9.4±2.4 to 9.5±2.5 MJ/d in men; 7.5±1.9 
MJ/d in women).
Table 2.1 Baseline characteristics of community-dwelling, frail, and institutionalized elderly 
people
COMMUNITY-DWELLING FRAIL INSTITUTIONAL
DNFCS 65–74 y 
(n=400)
DNFCS 75–97 y 
(n=307)
FRAIL 
(n=194)
INST-1 
(n=60)
INST-2 
(n=216)
Age (y)
Male 69.1±2.8 78.3±3.1 79.3±5.9 80.3±7.6 78.7±7.1
Female 69.4±2.9 78.5±3.9 77.8±5.3 80.2±6.5 81.1±7.8
Weight (kg)
Male 78.5±10.4 77.5±10.6 73.2±8.3 78.1±7.6 75.9±13.4
Female 72.4±13.3 70.1± 1.7 63.7±8.7 64.4±10.5 71.6±17.4
BMI (kg/m2)
Male 25.4±3.0 25.5±3.1 24.3±2.1 27.1±3.9 22.7±9.7
Female 26.8±4.6 25.8±3.9 24.5±2.9 25.6±3.8 27.2±9.2
DNFCS: Dutch national food consumption survey. INST-1: intervention 1 among institutionalized elderly 
people. INST-2: intervention 2 among institutionalized elderly people. Values are means ± SD.
35Dietary protein intake in the elderly
2
Lowest dietary protein intakes were observed in institutionalized elderly people showing 
a mean intake of 56±17 g/d for men and 55±15 g/d for women in the INST-2 study. The 
highest protein intakes, which averaged 85.9±23.9 g/d, were reported in community-
dwelling elderly men (Table 2.2). Dietary protein intake, expressed as g/kg-bw/d, was 
0.8±0.3 g/kg-bw/d in institutionalized elderly people, 1.0±0.3 g/kg-bw/d in frail elderly 
people, and 1.1±0.3 g/kg-bw/d in community-dwelling elderly people. Dietary protein 
intake of the institutionalized elderly people was significantly lower than the protein 
intake of community-dwelling elderly people (P<0.001) (Table 2.2). Furthermore, 21% 
of elderly people in the INST-1 study and 35% of the elderly people in the INST-2 study 
had a protein intake below the estimated average requirement (EAR), whereas 10% of 
the community-dwelling and frail elderly people had an intake below this reference. 
The distribution of protein intake across breakfast, lunch, dinner, and snacks times (i.e. in 
between meals) is presented in Figure 2.1. Dietary protein intake at breakfast was 10±10 g 
Table 2.2 Energy and protein intake in community-dwelling, frail, and institutionalized 
elderly people
COMMUNITY-DWELLING FRAIL INSTITUTIONAL
DNFCS 65–74 y 
(n=400)
DNFCS 75–97 y 
(n=307)
FRAIL 
(n=194)
INST-1 
(n=60)
INST-2 
(n=216)
Energy intake (MJ/d)
Male 9.4±2.4a 9.2±2.5a 8.7±2.0a 8.2±1.6a 5.8±1.5b
Female 7.5±1.9a 7.5±1.8ab 7.0±1.5bc 6.2±1.5cd 5.9±1.6d
Protein intake (g/d)
Male 85.9±23.9a 81.9±25.2ab 75.4±21.3b 66.9±18.8bc 56.3±17.1c
Female 72.9±18.2a 71.6±18.8a 62.4±14.9b 54.0±12.9c 55.5±15.4c
Protein intake (g/kg-bw/d)
Male 1.11±0.31a 1.07±0.35ab 1.04±0.29ab 0.86±0.22bc 0.78±0.28c
Female 1.03±0.35a 1.05±0.32a 1.00±0.27a 0.85±0.20b 0.81±0.29b
Protein intake (en%)
Male 15.8±3.5ab 15.3±3.2ab 14.8±2.9a 13.9±2.8a 16.4±2.6b
Female 16.9±3.9a 16.5±3.5ab 15.3±2.7c 15.0±3.0bc 16.3±2.5ac
DNFCS: Dutch national food consumption survey. INST-1: intervention 1 among institutionalized elderly 
people. INST-2: intervention 2 among institutionalized elderly people. Values are means ± SD. Values 
with different superscript letters indicate signifi cant differences in energy and protein intake of the 
elderly populations according to Bonferroni post hoc test (P<0.05).
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in community-dwelling, 8±5 g frail, and 12±6 g in institutionalized elderly people. During 
lunch the community-dwelling elderly people consumed on average 27±15 g protein 
per meal. Seventy percent of the community-dwelling elderly people consumed a bread 
containing meal, which contained 19±9 g protein per meal during lunchtime (data not 
shown). When a hot meal was used during lunch, the average protein intake was 39±16 
g and 35±9 g in elderly from the DNFC 65–74 y and DNFC 75–97 y study, respectively. 
Frail elderly people consumed on average 18±7 g of protein during lunchtime. In the 
institutionalized elderly people, the hot meal was consumed during lunchtime resulting in 
24±8 g and 25±8 g protein for the elderly people in respectively the INST-2 and INST-1 
study. During dinnertime the lowest protein intakes were found in the institutionalized 
elderly people because of the consumption of a bread meal.
During the day, mostly animal proteins (65%), especially from meat and dairy products, 
contributed to dietary protein intake (Table 2.3). During breakfast, 50% of the protein 
Figure 2.1 Daily protein intake in g distributed per mealtime in community-dwelling, 
frail, and institutionalized elderly people. DNFCS: Dutch national food consumption survey. 
INST-1: intervention 1 among institutionalized elderly people. INST-2: intervention 2 among 
institutionalized elderly people. Values are means ± SD. Snack 1 represents: Protein intake 
between breakfast and lunch. Snack 2 represents: Protein intake between lunch and dinner. 
Snack 3 represents: Protein intake after dinner.
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intake was derived from vegetable proteins in the community-dwelling elderly with bread 
as predominant source (41%). In the institutionalized elderly people, dietary protein was 
mostly derived from dairy products during breakfast (37% in the INST-1 study and 40% 
in the INST-2 study). During the hot meal, either served at lunchtime or at dinnertime, 
meat and dairy products prevailed. There were no gender differences in the distribution 
of protein intake and in the contribution of specific food sources to dietary protein intake.
Discussion
This study provides detailed information on dietary protein intake, the distribution of 
protein intake throughout the day, and intake of protein containing food sources in 
community-dwelling, frail, and institutionalized elderly people. Dietary protein intakes are 
well above the RDA in community-dwelling and frail elderly people. In institutionalized 
elderly people, a significant proportion showed an intake below the average protein 
requirement, which makes them an important target population for dietary interventions. 
Dietary protein intake was particularly low at breakfast with bread and dairy as main 
protein sources.
A major strength of the present analysis is that dietary intake data were collected from 
well characterized elderly population groups differing in health status. The community-
dwelling elderly subpopulation represents apparently healthy, independently nationwide 
living elderly people. This group was stratified into two different age groups in order to 
allow comparisons with frail and institutionalized elderly people, similar in age but with a 
different health status. As compared to community-dwelling elderly people, frail elderly 
people had a worse health profile and a lower physical activity level (PASE score of 85 vs. 
64)34. Considering and reflecting on the current widely used Fried criteria, we feel confident 
to have properly classified the population as being frail35-37. Institutionalized elderly people 
were described either as a borderline-demented, or as a somatic disordered population27. 
For comparative purposes, the use of the same methodology is important. In our study the 
same dietary assessment method, the dietary record, was used across studies. This method 
has been described as a suitable instrument for assessing energy and protein intake in 
elderly people38,39. The latter has also been validated against urinary nitrogen studies in 
both community-dwelling and institutionalized elderly people38. Despite the similarity in 
dietary assessment method, a possible limitation might be the difference in number of 
days (2-d food records and 3-d food records). Additional analysis, however, showed no 
differences in the level of dietary protein intake between a 2- or 3-d assessment in both 
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frail and institutionalized elderly (INST-2). Furthermore, variances of the protein intake 
in the different elderly subpopulations were equal indicating a limited effect of the one 
day difference. Another limitation might be the use of different food composition tables 
across studies. As a result of updating food composition tables, composition of several 
products might have been changed. However, comparison between the food composition 
tables showed similar protein content of the various food products.
In our study, we observed the lowest average protein intake in the institutionalized elderly 
(0.8±0.3 g/kg-bw/d). Thirty-five percent of this population reported a daily protein intake 
below the estimated average protein requirement of 0.7 g/kg-bw/d40. Yet on average, the 
protein intake equals the RDA of 0.8 g/kg-bw/d. It has been discussed that though the 
RDA for daily protein intake might be adequate to prevent deficiency in young adults, 
it may be insufficient to maintain health, including the preservation of skeletal muscle 
loss at a more advanced age15,41,42. Several experimental studies suggest greater needs 
for elderly people when compared with young individuals43,44. Moreover, a prospective 
study among 2066 community-dwelling elderly people suggests higher requirements, 
as a protein intake of 1.2 g/kg-bw/d was significantly associated with approximately 
40% less loss of lean body mass and appendicular lean body mass when compared with 
a protein intake of 0.8 g kg-bw/d after a 3 y period14. In view of these considerations, 
institutionalized elderly people, with an average protein intake of 0.8 g/kg-bw/d, would 
be an important target population for dietary interventions aiming to slow down or 
counteract sarcopenia.
In addition to daily protein intake, dietary protein intake with each meal might be important 
to maintain skeletal muscle mass in elderly people. Paddon-Jones et al. suggested that 
25–30 g of dietary protein per meal is required to maximally stimulate skeletal muscle 
protein synthesis15. Ingestion of smaller, meal-like amounts of dietary protein, i.e. less than 
20 g, attenuated the skeletal muscle protein synthetic response in elderly people when 
compared with young individuals17. In our study, we observed average protein intakes 
less than 12 g at breakfast. The latter protein intake is substantially below the proposed 
minimum of 20 g. Therefore, increasing the amount of dietary protein at breakfast to at 
least 20 g might represent a promising dietary strategy to enhance the skeletal muscle 
protein synthetic response in elderly people. 
Finally, the intake of specific protein containing food sources might be of importance to 
modulate the muscle protein synthetic response20-22. In our study, 65% of daily protein 
intake was derived from animal products in all elderly subpopulations. Also breakfast was 
relatively rich in animal protein sources, especially dairy (including cheese), egg, and meat 
Chapter 240
sources. Though it is evident that the amount of protein during breakfast is too low to 
attain a maximal post-prandial muscle protein synthetic response45, more work is needed 
to define the preferred protein source(s) that should be used to optimize post-prandial 
muscle protein synthetic response in elderly people. 
In summary, institutionalized elderly people are an important target population for dietary 
interventions since a significant proportion of institutionalized elderly showed an intake 
below the average protein requirement. Improving dietary protein intake in the morning 
might represent an interesting strategy for dietary interventions aiming to postpone and 
treat sarcopenia in elderly people.
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Abstract 
Objectives: Protein supplementation has been proposed as an effective dietary strategy 
to increase skeletal muscle mass and improve physical performance in frail elderly people. 
Our objective was to assess the impact of 24 wks dietary protein supplementation on 
muscle mass, strength, and physical performance in frail elderly people. 
Design/setting/participants: A total of 65 frail elderly subjects were included and 
randomly allocated to either daily protein or placebo supplementation (15 g protein at 
breakfast and lunch). 
Measurements: Skeletal muscle mass (DXA), muscle fiber size (muscle biopsy), strength 
(1-RM) and physical performance (SPPB) were assessed at baseline, after 12, and 24 wks 
of dietary intervention.
Results: Skeletal muscle mass did not change in the protein (from 45.8±1.7 to 45.8±1.7 
kg) or placebo supplemented group (from 46.7±1.7 to 46.6±1.7 kg) following 24 wks of 
intervention (P>0.05). In accordance, type I and II muscle fiber size did not change over 
time (P>0.05). Muscle strength increased significantly in both groups (P<0.01), with leg 
extension strength tending to increase to a greater extent in the protein (57±5 to 68±5 
kg) compared with the placebo group (57±5 to 63±5 kg) (treatment x time interaction 
effect: P=0.059). Physical performance improved significantly from 8.9±0.6 to 10.0±0.6 
points in the protein group and did not change in the placebo group (from 7.8±0.6 to 
7.9±0.6 points) (treatment x time interaction effect: P=0.02). 
Conclusions: Dietary protein supplementation improves physical performance, but does 
not increase skeletal muscle mass in frail elderly people. 
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Introduction 
Frailty is a geriatric syndrome of decreased reserves and resistance to stressors which 
results in an increased risk for adverse outcomes such as onset of disability, morbidity, 
institutionalization, and mortality1. An important and fundamental component of frailty 
is sarcopenia2. Sarcopenia is an age-related process characterized by the progressive loss 
of skeletal muscle mass, strength, and physical performance. The cause of sarcopenia is 
multi-factorial and includes a sedentary lifestyle and inadequate dietary protein intake3-5. It 
has been well-established that dietary protein ingestion stimulates skeletal muscle protein 
synthesis6-10, and inhibits protein breakdown, resulting in a positive protein balance9,10 
and net muscle protein accretion11-13. Consequently, it has been proposed that increasing 
dietary protein intake represents an effective strategy to increase skeletal muscle mass 
and strength and, as such, counteract sarcopenia and frailty14,15.
So far, evidence from long-term intervention studies shows no clear benefit of dietary 
protein supplementation on skeletal muscle mass in elderly people. Whereas some reveal 
an increase in skeletal muscle mass16,17, others have failed to report any measurable 
impact of long-term dietary protein supplementation on skeletal muscle mass in elderly 
subjects18-24. This apparent discrepancy might be attributed to the selection of healthy 
versus more frail elderly subjects. Most studies investigating the impact of long-term 
protein supplementation have generally included healthy elderly people18,21-24. Long-
term intervention studies investigating the efficacy of protein supplementation on 
skeletal muscle mass in frail elderly people, however, are scarce and show discrepant 
findings16,19,20. Whereas some report no effect of dietary protein supplementation on 
skeletal muscle mass and physical performance19,20, others have reported a significant 
increase in muscle power and a tendency for an increase in skeletal muscle mass after 
protein supplementation16. To underpin the possible benefits of protein supplementation 
on skeletal muscle mass and physical performance in a frail elderly population, more 
evidence from well-designed long-term intervention trials is needed. Therefore, we 
investigated, in a randomized, double-blind, placebo-controlled manner, the impact 
of 24 wks dietary protein supplementation (15 g dairy protein, twice daily) on skeletal 
muscle mass, muscle fiber type characteristics, strength, and physical performance in a 
large group (n=65) of frail elderly men and women.
Chapter 348
Methods
Subjects
Subjects with an age ≥65 y were recruited from an existing database of subjects, through 
distribution of information flyers, and by local information meetings organized between 
December 2009 and October 2010. Potentially eligible people were screened for pre-
frailty and frailty using the Fried criteria25. These criteria were: [1] unintentional weight 
loss, [2] weakness, [3] self-reported exhaustion, [4] slow walking speed, and [5] low 
physical activity. Subjects were considered pre-frail when 1 or 2 criteria were applicable 
and frail when 3 or more criteria were present. After screening for frailty, the medical 
history of the subjects was evaluated, and subjects who were diagnosed with cancer or 
COPD were excluded. In addition, a fasted blood sample was collected to screen for type 
2 diabetes and renal insufficiency. Subjects with type 2 diabetes, according to plasma 
glucose concentrations ≥7 mmol/L26, and subjects with renal insufficiency, according to 
an estimated global filtration rate (eGFR) <60 mL/min/1.73 m2 27, were excluded. None 
of the subjects had a history of participating in any structured exercise training program 
over the past 2 y. In total, 65 pre-frail and frail elderly men and women were included in 
the 24 wks supplementation trial. The Wageningen University Medical Ethical Committee 
approved the study and subjects gave their written informed consent.
Study design
After inclusion, subjects were randomly allocated to either the protein or the placebo 
supplemented group. An independent person randomized the subjects by means of 
computer-generated random numbers in stratified permuted blocks of size 4, stratified 
by gender. Primary outcome measure was lean mass measured by dual-energy X-ray 
absorptiometry (DXA). Secondary outcome measures included muscle fiber cross sectional 
area (CSA, muscle biopsy), strength (one repetition maximum; 1-RM, handgrip strength), 
and physical performance (short physical performance battery; SPPB). Furthermore, blood 
samples were collected to determine plasma glucose, insulin, and markers of renal function 
and 3-d food records were collected to assess habitual dietary intake. All measurements 
were assessed at baseline (0 wks), after 12 wks, and after 24 wks of intervention. Sample 
size was calculated based on a lean mass difference of 1.14 kg between the protein group 
and placebo group17. With a SD of 1.4 kg, based on previously collected DXA data, a 
minimum of 24 subjects per treatment group would be required to detect a difference 
(power=80%, α=0.05). With an expected drop-out rate of 25%, a sample size of 30 subjects 
per treatment group was considered adequate.
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Protein supplementation
Twice daily, subjects received either a 250 mL beverage containing 15 g protein (milk 
protein concentrate (MPC80), 7.1 g lactose, 0.5 g fat, and 0.4 g calcium, or a matching 
250 mL placebo beverage containing no protein, 7.1 g lactose, and 0.4 g calcium 
(FrieslandCampina Consumer Products Europe, Wageningen, The Netherlands). The 
subjects consumed one beverage after breakfast and one beverage after lunch. All 
beverages were provided in non-transparent packages and were vanilla flavored to mask 
the contents of the drinks.
Anthropometrics and body composition
Height was measured at baseline with a wall-mounted stadiometer to the nearest 0.1 cm. 
Body weight was measured in the fasted state to the nearest 0.1 kg with a calibrated digital 
scale (ED-6-T; Berkel, Rotterdam, The Netherlands). In the fasted state, body composition 
and bone mineral density were measured by DXA (Lunar Prodigy Advance; GE Health 
Care, Madision, WI). DXA quality-assurance measurements were performed to ensure 
scanner reliability, and identical patient scan protocols were performed for all subjects.
Maximum strength and physical performance
Maximum strength was assessed by one repetition maximum (1-RM) strength tests on 
leg press and leg extension machines (Technogym, Rotterdam, the Netherlands). During a 
first familiarization session, the proper lifting technique was demonstrated and practiced, 
after which maximum strength was estimated using the multiple repetitions testing 
procedure for leg press and leg extension. In a second exercise session, ≥1 wk after the 
first strength estimation, the subjects’ 1-RM strength was determined5. Handgrip strength 
was measured using a hydraulic hand dynamometer (Jamar, Jackson, MI, USA,). Three 
consecutive measures of handgrip strength at both hands were recorded to the nearest 
0.5 kg with subjects sitting in an upward position and the arm in a 90 degrees angle 
position. The maximum strength effort was reported. Physical performance was assessed 
by the short physical performance battery (SPPB), which consists of three components: 
balance, gait speed, and chair rise ability28. Scores of 1 to 4 were based on categories of 
performance in the balance tests, on the time necessary to complete the walk, and on 
the time needed to perform the chair rise test. If subjects were unable to perform a test, 
they received a score of 0. A summary performance score of 0 to 12 was calculated by 
summing the scores of the 3 tests.
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Blood sampling 
After an overnight fast, blood samples were collected in EDTA-containing tubes and 
in serum tubes. EDTA-containing tubes were centrifuged at 1000g at 4˚C for 10 min 
and serum tubes were centrifuged 90 min after the blood collection at 1000g at 20˚C 
for 15 min. Aliquots of plasma and serum were frozen in liquid nitrogen and stored at 
-80˚C. Plasma samples were analyzed to determine glucose and insulin concentrations 
and serum samples were analyzed to determine creatinine concentrations to assess the 
estimated global filtration rate (eGFR)29. Plasma glucose concentrations were measured 
with a COBAS FARA analyzer (Uni Kit III; Roche, Basel, Switzerland). Insulin was measured 
by radioimmunoassay (Insulin RIA Kit; LINCO Research Inc, St Charles, MO). Serum 
creatinine was measured by using Roche Modular System P (Roche Diagnostics GmbH, 
Mannheim, Germany).
Muscle biopsy sampling and immunohistochemistry
After local anesthesia, percutaneous needle biopsy samples (50–80 mg) were collected 
following an overnight fast from the vastus lateralis muscle, ~15 cm above the patella30. 
Any visible non-muscle tissue was removed immediately, and biopsy samples were 
embedded in Tissue-Tek (Sakura Finetek, Zoeterwoude, The Netherlands), frozen in liquid 
nitrogen-cooled isopentane, and stored at -80°C until further analyses.
From all biopsies, 5 μm thick cryosections were cut at -20˚C. Muscle biopsies were 
stained for muscle fiber typing as described in detail previously31. In short, the slides 
were incubated with primary antibodies against MHC-I (A4.840, Developmental Studies 
Hybridoma Bank, Iowa City, IA) and laminin (polyclonal laminin, Sigma, Zwijndrecht, the 
Netherlands). After washing, appropriate secondary antibodies were applied (goat anti-
mouse IgM AlexaFluor555 and goat anti-rabbit IgG AlexaFluor647, respectively; Molecular 
Probes, Invitrogen, Breda, the Netherlands). Images were visualized and automatically 
captured at 10x magnification with a fluorescent microscope equipped with an automatic 
stage (IX81 motorised inverted microscope, Olympus, Hamburg, Germany). Muscle fiber 
type (fiber%) and fiber size were measured for each separate muscle fiber. All image 
recordings and analyses were performed by an investigator blinded to subject coding.
Dietary intake
The subjects recorded their food intake for 3 d. The days of recording were randomly 
assigned so that all days of the week, including weekend days, were equally represented. 
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Trained dieticians gave oral and written instructions about recording type of foods and 
estimating portion sizes in household measures. At a second visit, dieticians checked the 
food records for completeness, obtained additional information about unclear items or 
amounts, and used examples household measures to improve the estimation of portion 
sizes. Dietary intake data were coded (type of food, time of intake, and amount) and 
energy and macronutrient intakes were calculated using food calculation system (BAS 
nutrition software 2004, Arnhem, The Netherlands) in which the Dutch food composition 
database 2006 was included.
Health status
Overall health status of the subjects was assessed using the 12-Item Short Form Health 
Survey (SF-12). This is a short form of the widely used SF-36. The SF-12 generates a 
physical composite score and mental composite score, which are well-validated measures 
of general physical and mental health, respectively. Higher physical and mental composite 
scores indicate better health32.
Blood pressure
After 10 min of supine rest, 4 blood pressure measurements with 2 min intervals were 
performed in the morning following an overnight fast, using a validated automatic blood 
pressure device (Omron HEM-907, Lake Forest, IL, USA). The first measurement was 
discarded and the subsequent 3 measurements were averaged.
Cognitive function
The Mini-Mental State Examination (MMSE) was used to screen for possible cognitive 
disorders. The score ranges from 0 to 30. A score >25 was used as a cut-off value for the 
absence of cognitive disorders33.
Statistics
Data analysis was performed by the intention to treat principle and according to a 
predefined data analysis plan. Data are expressed as means±SEM. Baseline characteristics 
were compared between treatment groups using an independent student T-test. 
Differences between treatments over time were analyzed using mixed linear models with 
Toeplitz covariance structure. Time, treatment, and their interaction were defined as fixed 
factors and subject was defined as a random factor. Muscle fiber type characteristics 
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were analyzed by adding an additional within-subjects factor (fiber type) in the model. 
All statistical analyses were performed using SPSS Statistics v19. An α-level of 0.05 was 
used to determine statistical significance.
Results
Subjects
Between December 2009 and October 2010, 734 subjects were invited to participate in 
the study of which 165 subjects were screened. A total of 65 subjects fulfilled the frailty 
criteria and were found eligible to include into the study. In total, 8 subjects withdrew from 
the study, 4 in each group. For the intention to treat analyses, 4 dropouts were willing to 
have final assessments. Since there were no differences in primary and secondary outcome 
measures between the intention to treat analyses and the per protocol analysis, all data 
were analyzed according to the intention to treat principle. Baseline characteristics are 
presented in Table 3.1 and showed no significant differences between groups (P>0.05). 
Table 3.1 Subjects’ characteristics
 Variable Placebo (n=31) Protein (n=34)
Age (y) 81±1 78±1
Female / Male (#) 16/15 20/14
Weight (kg) 73.8±2.2 73.9±2.4
Height (m) 1.67±0.02 1.65±0.02
BMI (kg/m2) 26.2±0.6 27.0±0.6
MMSE (points) 27.4±0.4 27.6±0.5
PCS12 (points) 42.7±1.8 43.9±1.7
MCS12 (points) 54.9±1.4 54.0±1.3
Glucose (mmol/L) 5.3±0.1 5.2±0.1
Insulin (mU/L) 18.0±1.2 18.0±1.2
eGFR (mL/min/1.73 m2) 77.6±3.2 84.4±3.1
Systolic BP (mmHg) 150±4 152±4
Diastolic BP (mmHg) 75±2 76±2
Data represent means±SEM. BMI: Body Mass Index. MMSE: Mini Mental State Examination. PCS12: Physical 
component score SF12. MCS12: Mental component score SF12. eGFR: estimated Globular Filtration Rate. 
BP: Blood pressure. No differences between groups (P>0.05).
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The average MMSE score was 27.4±0.4 and 27.6±0.5 points in the placebo and protein 
group, respectively, indicating an absence of cognitive disorders. The average adherence 
to the treatment based on ticked calendars and non-consumed beverages was ≥92% 
and did not differ between groups.
Body composition
No significant time, treatment, or treatment x time interaction effects were observed on 
any of the body composition parameters (Table 3.2: P>0.05). Lean body mass did not 
increase in the protein (from 45.8±1.7 to 45.8±1.7 kg) or placebo group (from 46.7±1.7 
to 46.6±1.7 kg; Figure 3.1). In accordance, type I and II muscle fiber size did not change 
during the intervention in both the placebo and protein supplemented group (P>0.05) 
Type II muscle fiber size was smaller compared with type I muscle fiber CSA (P<0.05).
Muscle strength
Muscle strength parameters are presented in Table 3.3. At baseline, muscle strength 
did not differ between the protein and placebo group (P>0.05). After 24 wks, handgrip 
strength in both groups had not improved (P>0.05). Muscle strength, assessed at the leg 
press, had significantly increased from 124±9 to 139±9 kg in the placebo group and from 
Table 3.2 Body composition at baseline (0 wks), after 12 wks, and after 24 wks of intervention 
in the placebo and protein group
Placebo Protein
Variable 0 wks 12 wks 24 wks 0 wks 12 wks 24 wks
Body weight (kg)a 73.8±2.2 74.1±2.3 73.3±2.3 73.9±2.4 74.5±2.3 74.3 ± 2.2
Fat mass (kg)b 23.9±1.5 24.0±1.5 23.4±1.5 25.3±1.5 25.2±1.5 25.3±1.5
ALM (kg)b 19.5±0.8 19.4±0.8 19.6±0.8 19.2±0.8 19.4±0.8 19.3±0.8
Type I muscle fiber CSA 
(mm2)c 4.6±0.3 4.2±0.3 4.1±0.3 4.6±0.3 5.4±0.3 5.1±0.3
Type II muscle fiber 
CSA (mm2)c 2.9±0.3 2.8±0.3 3.0±0.3 3.4±0.3 4.1±0.3 3.3±0.3
BMC (kg)b 2.6±0.1 2.6±0.1 2.6±0.1 2.5±0.1 2.5±0.1 2.5±0.1
Data represent means±SEM. ALM: Appendicular lean mass. CSA: Cross sectional area. BMC: Bone Mineral 
Content. Intention to treat data were analyzed using a mixed linear model (a n=65; b n=62, c n=46). No 
significant treatment x time interaction or main effects were observed (P>0.05).
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118±8 to 136±8 kg in the protein group, with no significant treatment x time interaction 
effect (P>0.05). Muscle strength assessed at the leg extension, however, did reveal a trend 
treatment x time interaction effect (P=0.059), reflecting a borderline significantly greater 
increase in muscle strength in the protein group (57±5 to 68±5 kg) compared with the 
placebo group (57±5 to 63±5 kg).
Figure 3.1 Intention to treat analysis on total lean mass in the placebo and protein group 
(n=62). Data represents means±SEM. There was a no significant treatment x time interaction 
effect or main effects (P>0.05).
Table 3.3 Muscle strength and physical performance at baseline (0 wks), after 12 wks, and 
after 24 wks of intervention in the placebo and protein group
Placebo Protein
Variable 0 wks 12 wks 24 wks 0 wks 12 wks 24 wks
Leg press strength 
(kg)a 124±9 129±9 139±9 118±8 121±8 136±8
Leg extension 
strength (kg)a 57±5 59±5 63±5 57±5 64±5 68±5
Handgrip strength 
(kg)b 26±2 27±2 26±2 26±2 25±2 26±2
Gait speed (sec)c 6.1±0.6 6.4±0.6 6.3±0.6 5.5±0.6 5.6±0.6 5.6±0.6
Chair rise (sec)d 11.9±1.1 13.7±1.1 14.1±1.2 13.2±1.0 11.7±1.0 11.1±1.1
Data represents means±SEM. Intention to treat data were analyzed using a mixed linear model (a n=50; b 
n=65, c n=61, d n=48). Leg press data showed a significant time effect (P<0.001) and no treatment x time 
interaction effect (P>0.05). Leg extension data showed a trend treatment x time interaction effect (P=0.059) 
and a significant time effect (P<0.0001). Chair rise data showed a trend treatment x time interaction effect 
(P=0.055). Handgrip and gait speed data showed no interaction or main effects (P>0.05).
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Physical performance 
Physical performance (SPPB) data are presented in Figure 3.2. At baseline, no significant 
difference in total SPPB score was observed between the placebo and protein group 
(P>0.05). After 24 wks, a significant treatment x time interaction effect was found 
(P=0.02). Physical performance improved significantly from 8.9±0.6 to 10.0±0.6 points 
in the protein group and showed no improvements in the placebo group (from 7.8±0.6 
to 7.9±0.6 points). Of the 3 components of the SPPB, chair rise ability showed the most 
pronounced difference between the protein and placebo group (Table 3.3). After 24 wks, 
the ability to stand up from a chair tended to be faster in the protein group (13.7±1.0 to 
11.1±1.1 sec) compared with the placebo group (11.9±1.1 to 14.1±1.2 sec; P-value for 
treatment x time interaction = 0.055).
Blood measurements
Baseline plasma glucose and insulin concentrations are presented in Table 3.1. Glucose 
and insulin concentrations did not differ at baseline and did not change over time in 
either group (data not shown). The estimated globular filtration rates (eGFR) did not differ 
between groups at baseline (Table 3.1) and did not change over time (data not shown).
Dietary intake
Dietary intake data are presented in Table 3.4. Baseline daily protein intake was 1.0 
g/kg-bw/d and did not change significantly overtime in either group (P>0.05). Daily 
Figure 3.2 Intention to treat analysis on physical performance (SPPB) in the placebo and 
protein group (n=61). Data represents means±SEM. There was a significant treatment x time 
interaction effect (P=0.02).
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protein intake at breakfast, lunch, and dinner did not differ between groups prior to the 
intervention and did not change over time. With the addition of the protein supplements, 
15 g protein at breakfast and 15 g protein at lunchtime, the daily protein intake increased 
from 1.0 to 1.4 g/kg-bw/d in the protein group during the intervention. No significant 
baseline differences in daily energy and macronutrient intake were observed between 
groups (P>0.05). After 24 wks, daily energy intake was significantly reduced (P=0.04), 
with no significant differences over time between groups (P>0.05). Fat and carbohydrate 
intake did not differ between the groups and did not change over time (P>0.05).
Health status, blood pressure and cognitive function
Health status (SF-12 scores), blood pressure and cognitive function (MMSE) parameters 
did not differ between groups at baseline (Table 3.1) and did not change over time in 
either group (data not shown).
Table 3.4 Habitual dietary intake (without protein supplements)
Placebo Protein
Variable 0 wks 12 wks 24 wks 0 wks 12 wks 24 wks
Energy intake (MJ/d) 8.1±0.4 8.1±0.4 7.8±0.4 8.1±0.4 7.3±0.4 7.5±0.4
Protein intake (g/d) 74±4 74±4 74±4 78±4 71±4 71±4
Protein (g/kg-bw/d) 1.0±0.0 1.1±0.1 1.0±0.1 1.0±0.0 1.1±0.1 1.0±0.1
Protein at breakfast (g) 11±1 11±1 12±1 13±1 12±1 12±1
Protein at lunch (g) 19±2 17±2 18±2 20±2 18±2 17±2
Protein at dinner (g) 32±2 35±2 33±2 32±2 29±2 29±2
Protein (en%) 16±1 16±1 17±1 16±1 17±1 16±1
Fat (en%) 33±1 35±1 34±1 36±1 36±1 35±1
Carbohydrate (en%) 48±1 46±1 46±1 44±1 44±1 44±1
Data represent means±SEM. en%: energy percentage. Intention to treat data were analyzed using a 
mixed linear model (n=65). Energy intake data showed no treatment x time interaction effect (P=0.60). 
A significant time effect was observed (P=0.04). There was no significant treatment, time, or treatment x 
time interaction effect of any of the other variables.
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Discussion
The present study shows that 24 wks of dietary protein supplementation did not augment 
skeletal muscle mass in frail elderly people. In contrast, physical performance had improved 
significantly following dietary protein supplementation.
In the present study, we aimed to investigate the impact of long-term dietary protein 
supplementation on skeletal muscle mass, strength, and physical performance in frail 
elderly men and women. To include an adequate sample of frail elderly subjects, a large 
group of elderly people were informed (n=734) and screened (n=165) to select 65 subjects 
that met the frailty criteria described by Fried et al.25. These criteria have been reported 
to be highly predictive for falls, hospitalization, disability, and mortality25. In agreement, 
the selected subjects were characterized by low baseline physical performance (Figure 
3.2) and poor handgrip strength (Table 3.3), which confirms their frailty.
Compliance of the subjects to the dietary intervention, providing either protein (15 g) 
or placebo twice daily, was excellent. After 24 wks of dietary intervention, ≥92% of the 
provided drinks were consumed in both the protein and placebo supplemented group, 
showing that the consumption of 2 supplements per day was well tolerated. Although, 
we observed a reduction in daily energy intake over time, we observed no reduction in 
daily protein intake during the intervention (Table 3.4). Consequently, daily protein intake 
increased from 1.0±0.1 towards 1.4±0.1 g/kg-bw/d following protein supplementation, 
whereas in the placebo group daily protein intake did not change over time (1.0±0.1 
g/kg-bw/d). Previous assessment of dietary protein intake in elderly subpopulations 
in the Netherlands has shown that daily protein intake is not equally distributed over 
the various main meals, and that breakfast and lunch are particularly low in protein34. 
In agreement, the frail elderly subjects consumed 13±1, 20±2 and 32±2 g protein with 
breakfast, lunch, and dinner, respectively, prior to intervention. By supplementing the 
subjects in the protein group with 15 g protein twice daily, protein intake increased to 
more than 25 g of protein with each main meal. In contrast, in the control group, the 
subjects ingested relative small amounts of dietary protein at breakfast (11±1 g) and 
lunch (17±2 g) during the intervention34.
It has been suggested that 20-25 g of dietary protein per meal is required to allow an 
appropriate stimulation of post-prandial muscle protein synthesis8,35-37. Ingestion of smaller 
amounts of dietary protein has been reported to attenuate the skeletal muscle protein 
synthetic response in elderly people38. We hypothesized that increasing dietary protein 
intake at breakfast and lunch would stimulate post-prandial muscle protein synthesis 
and decrease muscle protein breakdown, resulting in a more positive protein balance 
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after each meal, resulting in net skeletal muscle protein accretion following 24 wks of 
intervention34,36,39. Despite the greater protein intake at both breakfast and lunch in the 
protein group, no measurable gains in skeletal muscle mass were detected on a whole- 
body or muscle fiber level. Our data seem to be in line with most previous publications 
showing no measurable effect of protein supplementation on skeletal muscle mass in 
elderly people18-24,40. We anticipated a 1.14 kg increase in muscle mass following 24 wks of 
protein supplementation. With a population size of 65, a significance level of 0.05, and a 
power of 0.8, the limit for a statistically detectable change in skeletal muscle mass would 
have been 1.0±1.4 kg, which is easily detected by DXA scanning (with a CV for lean tissue 
<0.5%). However, it should be noted that differences smaller than 1.0 kg would not have 
been detectable, but could still be of considerable clinical benefit over the course of years.
Despite the absence of a measurable gain in skeletal muscle mass following prolonged 
dietary protein supplementation in frail elderly people, we observed significant 
improvements in physical performance in the protein group (Figure 3.2). The SPPB score 
increased from 8.9±0.6 to 10.0±0.6 points in the protein group, whereas in the placebo 
the SPPB remained unchanged (7.8±0.6 to 7.9±0.6 points). Such an increase in physical 
performance is of substantial clinical relevance41,42 and translates to a 30% relative risk 
reduction for disability43 and a reduced risk for institutionalization and mortality28. In 
agreement with the SPPB, we observed a strong tendency (P=0.059) of greater gains 
in leg extension strength in the protein supplemented group when compared with the 
placebo group. Our findings tend to be in line with previous data showing that protein 
supplementation improves physical performance in frail elderly people in the absence 
of measurable increases in skeletal muscle mass16. The improvements in physical 
performance without a significant increase in skeletal muscle mass may be attributed 
to the absence of a linear relationship between skeletal muscle mass, strength, and 
physical performance44,45. In fact, changes in muscle strength and/or physical performance 
are generally observed before measurable changes in skeletal muscle mass become 
apparent46. The latter observation suggests that clinically relevant increases in strength 
and physical performance can be achieved without measurable increases in whole-body 
or appendicular lean mass. Furthermore, it could be speculated that such improvements 
in physical performance in the protein supplemented group are due to improvements 
in neuromuscular action and/or skeletal muscle quality47. More research is warranted to 
study the impact of greater dietary protein provision on muscle strength and physical 
performance in frail elderly people.
In the present study, we show that protein supplementation improves physical 
performance. Moreover, the increase in daily protein ingestion from 1.0 to 1.4 g/kg-
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bw/d achieved by the supplements was not accompanied by any health complaints or 
side effects and did not affect renal function throughout the intervention period. These 
results and others16 point towards the application of dietary protein supplementation in 
frail elderly people as a promising nutritional strategy to improve physical performance, 
attenuate the progression of frailty, and delay the onset of disability.
We concluded that long-term dietary protein supplementation (15 g dairy protein, twice 
daily) improves physical performance, but does not increase skeletal muscle mass in frail 
elderly people.
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Abstract 
Background: Protein supplementation has been proposed as an effective dietary 
strategy to augment the skeletal muscle adaptive response to prolonged resistance-type 
exercise training in elderly people. Our objective was to assess the impact of protein 
supplementation on muscle mass, strength, and physical performance during prolonged 
resistance-type exercise training in frail elderly men and women. 
Methods: We performed a randomized, double-blind, placebo-controlled trial with 2 arms 
in parallel among 62 frail elderly subjects (78±1 y). These elderly subjects participated in 
a progressive resistance-type exercise training program (2 sessions per wk for 24 wks) 
during which they were supplemented twice daily with either protein (2 * 15 g) or a 
placebo. Lean body mass (DXA), strength (1-RM) and physical performance (SPPB) were 
assessed at baseline, after 12, and 24 wks of intervention. 
Results: Lean body mass increased from 47.2 kg (95% CI, 43.5–50.9) to 48.5 kg (95% 
CI, 44.8–52.1) in the protein group and did not change in the placebo group (from 45.7 
kg, 95% CI, 42.1–49.2 to 45.4 kg, 95% CI, 41.8–48.9) following the intervention (P-value 
for treatment x time interaction = 0.006). Strength and physical performance improved 
significantly in both groups (P=0.000) with no interaction effect of dietary protein 
supplementation. 
Conclusions: Prolonged resistance-type exercise training represents an effective strategy 
to improve strength and physical performance in frail elderly people. Dietary protein 
supplementation is required to allow muscle mass gain during exercise training in frail 
elderly people. 
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Introduction 
Frailty is a geriatric syndrome of decreased reserves and resistance to stressors, which 
increases the risk for adverse outcomes such as the onset of disability, morbidity, and 
institutionalization1,2. An important and fundamental  component of frailty is sarcopenia3. 
Sarcopenia is characterized by a progressive loss of skeletal muscle mass, strength, 
and physical performance4. The cause of sarcopenia is multi-factorial and includes a 
sedentary lifestyle and inadequate protein intake5-7. A single session of resistance-type 
exercise increases both muscle protein synthesis and breakdown rates, albeit the latter 
to a lesser extent8,9. Although exercise improves muscle protein balance, net balance 
will remain negative in the absence of food intake. Protein ingestion prior to or after 
exercise is required to further augment post-exercise muscle protein synthesis rates and 
inhibit protein breakdown8,10-12, resulting in a positive protein balance and, as such, net 
muscle protein accretion13-16. Consequently, it has been proposed that dietary protein 
supplementation is required to maximize skeletal muscle mass gain during prolonged 
resistance-type exercise training and, as such, to more effectively counteract sarcopenia 
and frailty17,18.
So far, there is ample evidence reporting beneficial effects of long-term resistance-type 
exercise training on muscle mass and performance in healthy elderly people19-25. In 
contrast, studies investigating the impact of such prolonged exercise interventions in frail 
elderly are scarce and report discrepant findings17,18,26. Whereas Fiatarone et al. showed 
a significant increase in muscle mass after 10 wks of resistance-type exercise training26, 
others have failed to detect measurable increases in muscle mass and/or physical 
performance in frail elders27,28. We hypothesized that dietary protein supplementation is 
needed to increase muscle mass, strength, and physical performance during prolonged 
resistance-type exercise training in frail elderly people. Therefore, 62 frail elderly men 
and women were selected to participate in a 24 wk supervised resistance-type exercise 
training program during which they were supplemented with or without additional dietary 
protein (2 * 15 g daily) in a randomized, double-blind, placebo-controlled, manner.
Methods
Subjects
Elderly subjects (≥65 y) were recruited from an existing database, through distribution 
of flyers, and by local information meetings between December 2009 and September 
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2010. Potentially eligible elderly people were screened for pre-frailty and frailty using 
the Fried criteria2. These criteria were: [1] unintentional weight loss, [2] weakness, [3] 
self-reported exhaustion, [4] slow walking speed, and [5] low physical activity. Pre-frailty 
was classified when one or two criteria were present and frailty was defined when three 
or more criteria were present. Medical history of all subjects was evaluated. Subjects who 
were diagnosed with cancer, COPD, muscle disease or who were unable to perform the 
exercise regimen were excluded. Subjects with type 2 diabetes (≥ 7 mmol/L)29 and renal 
insufficiency (eGFR <60 mL/min/1.73 m2)30 were excluded. A resting electrocardiogram 
was performed to exclude silent ischemia. The Wageningen University Medical Ethical 
Committee approved the study and subjects gave their written informed consent.
Study design
After inclusion, subjects were randomly allocated to either protein or placebo 
supplementation. Both groups were included in a 24 wk resistance-type exercise 
training program. An independent person randomized subjects by means of computer-
generated random numbers in stratified permuted blocks of size four, stratified by 
gender. Primary outcome measure was lean body mass measured by dual-energy X-ray 
absorptiometry (DXA). Secondary outcome measures included maximum strength (one 
repetition maximum; 1-RM, handgrip strength), and physical performance (short physical 
performance battery; SPPB). In addition, blood samples were collected to determine 
plasma glucose and insulin concentrations and markers for renal functional decline. 
Furthermore, 3-d food records were collected to define habitual dietary intake. All 
measures were collected prior to and after 12 and 24 wks of intervention.
Resistance-type exercise training program
The resistance-type exercise training was performed 2 times per wk under personal 
supervision for a 24 wk period. The sessions were performed in the morning and afternoon 
with at least 72 h between sessions. The training consisted of a 5 min warm-up on a cycle 
ergometer, followed by 4 sets on the leg press and leg extension machines and 3 sets on 
chest press, lat pulldown, pec-dec, and vertical row machines (Technogym, Rotterdam, the 
Netherlands). The workload started at 50% of 1-RM (10–15 repetitions per set) and was 
increased to 75% of 1-RM (8–10 repetitions) to stimulate muscle hypertrophy. Resting 
periods of 1 min were allowed between sets and 2 min between exercises. To evaluate 
changes in muscle strength, 1-RM was repeated after 4, 8, 12, 16, and 20 wks of training. 
Workload intensity was adjusted based on the 1-RM outcomes.
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Protein supplementation
Twice daily, the subjects received either a 250 mL protein supplemented beverage 
containing 15 g protein (MPC80; milk protein concentrate), 7.1 g lactose, 0.5 g fat, and 
0.4 g calcium, or a matching placebo supplement containing no protein, 7.1 g lactose, 
and 0.4 g calcium (FrieslandCampina Consumer Products Europe, the Netherlands). 
All beverages were vanilla flavored to mask the contents of the drinks and packages 
were non-transparent. The subjects consumed 1 beverage directly after breakfast and 1 
beverage directly after lunch. Staff members and subjects were blinded towards treatment 
allocation until completion of data analysis.
Body composition
Height was measured at baseline with a wall-mounted stadiometer to the nearest 0.1 
cm. Body weight was measured in the fasted state to the nearest 0.1 kg with a calibrated 
digital scale (ED-6-T; Berkel, Rotterdam, The Netherlands). In the fasted state, lean body 
mass, fat mass and bone mineral density were measured by DXA (Lunar Prodigy Advance; 
GE Health Care, Madision, WI, USA).
Maximum strength and physical performance
Maximum strength was assessed by 1-RM strength tests on leg press and leg extension 
machines (Technogym, Rotterdam, the Netherlands). During a first familiarization session, 
the proper lifting technique was practiced, after which maximum strength was estimated. In 
a second session, 1-RM strength was determined10. Handgrip strength was measured using 
a hydraulic hand dynamometer (Jamar, Jackson, MI, USA). Three consecutive measures of 
handgrip strength (kg) at both hands were recorded to the nearest 0.5 kg with subjects sitting 
in an upward position and the arm in a 90 degree angle. Physical performance was assessed 
by the SPPB, which consists of 3 components: balance, gait speed, and chair rise ability31. 
Scores of 1 to 4 were based on categories of performance in the balance tests, on the time 
necessary to complete the walk and on the time needed to perform the chair-rise test. A 
summary performance score of 0 to 12 was calculated by summing the scores of the tests.
Blood sampling
Following an overnight fast, blood samples were collected in EDTA-containing and serum 
tubes. EDTA-containing tubes were centrifuged at 1000g at 4˚C for 10 min and serum 
tubes were centrifuged 90 min after the blood collection at 1000g at 20˚C for 15 min. 
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Aliquots of plasma and serum were frozen in liquid nitrogen and stored at -80˚C. Plasma 
glucose concentrations were measured with a COBAS FARA analyzer (Uni Kit III; Roche, 
Basel, Switzerland). Plasma insulin concentrations were measured by radioimmunoassay 
(Insulin RIA Kit; LINCO Research Inc, St Charles, MO, USA). Serum creatinine concentrations 
were measured by using Roche Modular System P (Roche Diagnostics GmbH, Mannheim, 
Germany).
Dietary intake
The subjects recorded their food intake for 3 d. The days of recording were randomly 
assigned so that all days of the week, including weekend days, were equally represented. 
Trained dieticians gave oral and written instructions about recording type of foods and 
estimating portion sizes in household measures. During a second visit, dieticians checked 
the food records for completeness, obtained additional information about unclear items or 
amounts, and used examples of household measures to improve the estimation of portion 
sizes. Dietary intake data were coded (type of food, time of intake, and amount) and 
energy and macronutrient intakes were calculated using a food calculation system (BAS 
nutrition software 2004, Arnhem, The Netherlands) in which the Dutch food composition 
database 2006 was included.
Health status
Overall health status of the subjects was assessed using the 12-Item Short Form Health 
Survey (SF-12). The SF-12 generates a physical composite score (PCS12) and mental 
composite score (MCS12). Higher physical and mental composite scores indicate better 
health32.
Blood pressure
After 10 min of supine rest, 4 blood pressure measurements with 2 min intervals were 
performed in the morning following an overnight fast, using a validated automatic blood 
pressure device (Omron HEM-907, Lake Forest, IL, USA). The first measurement was 
discarded and the subsequent 3 measurements were averaged.
Cognitive function
The Mini-Mental State Examination (MMSE) was used to assess cognitive function33. The 
score ranges from 0 to 30. A higher score represents a better cognitive function.
71Protein supplementation and exercise in frail elderly people
4
Statistical analysis
Sample size was calculated based on an expected difference in lean body mass of 1.1 kg 
between groups34. With an SD of 1.4 kg, a minimum of 24 subjects per treatment group 
would be required to detect a difference (power=80%, α=0.05). With an expected drop-
out rate of 25%35,36, a sample size of 30 subjects per treatment group was considered 
adequate. Data analysis was performed by the intention to treat principle and according 
to a predefined data analysis plan. Means for baseline and follow-up data were expressed 
with SD, SEM or 95% confidence intervals (95% CI). Baseline characteristics were compared 
between treatment groups using an independent student T-test. Differences between 
treatments over time were analyzed using mixed linear models with Toeplitz covariance 
structure. Time, treatment, and their interaction were defined as fixed factors and subject 
was defined as a random factor. All statistical analyses were performed using SPSS Statistics 
v19. An α-level of 0.05 was used to determine statistical significance.
Results
Between December 2009 and October 2010, 686 subjects were invited to participate in 
the study, 233 subjects were screened, and 62 subjects were included in the study. In 
total, 11 subjects withdrew from the study: 5 from the protein and 6 from the placebo 
group. Ten subjects gave various non-study related medical complications as reasons for 
their withdrawal and 1 subject gave heavy burden of the study as reason for withdrawal. 
For the intention to treat analyses, 4 dropouts were willing to have final assessments 
(Figure 4.1). The average adherence to the treatment, based on ticked calendars and non-
consumed returned beverages, was ≥98% and did not differ between groups (P>0.05). 
Baseline characteristics are presented in Table 4.1 and showed no baseline differences 
between groups (P>0.05).
Body composition
Lean body mass increased from 47.2 (95% CI, 43.5–50.9) to 48.5 kg (95% CI, 44.8–52.1) 
in the protein group, and did not change in the placebo group (from 45.7 kg, 95% CI, 
42.1–49.2 to 45.4 kg, 95% CI, 41.8–48.9) following 24 wks of intervention (Figure 4.2: 
P-value for treatment x time interaction = 0.006) The most apparent increase in lean mass 
in the protein group was in the extremities. Appendicular lean mass increased from 20.1 
(95% CI, 18.3–21.8) to 21.0 kg (95% CI, 19.2–22.7) in the protein group only (Table 4.2: 
P-value for treatment x time interaction <0.001). Fat mass increased from 27.8 (95% CI, 
Chapter 472
23.8–31.4) to 28.5 kg (95% CI, 24.7–32.3) in the protein group and did not increase in the 
placebo group (from 28.4 kg, 95% CI, 24.8–32.1 to 27.9 kg, 95% CI, 24.2–31.6; P-value for 
treatment x time interaction <0.001).
Strength and physical performance
Strength and physical performance data are presented in Table 4.3. Leg press and leg 
extension strength improved over time in both the protein and placebo group (P<0.001) 
with no significant treatment x time interaction effect. In accordance, physical performance 
(SPPB) improved significantly from 8.0 (95% CI, 7.2–8.9) to 9.5 points (95% CI, 8.6–10.3) 
in the protein group and from 7.9 (95% CI, 7.0–8.8) to 9.2 points (95% CI, 8.3–10.1) in the 
placebo group with no treatment x time interaction (P>0.05).
Figure 4.1 Participant flow.
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Blood measurements and renal function
Baseline plasma glucose and insulin concentrations are presented in Table 4.1. Glucose 
and insulin concentrations did not change over time in either group (data not shown). 
The estimated glomerular filtration rates (eGFR) did not differ between groups at baseline 
(Table 4.1) and did not significantly changed from 80.6 (95% CI, 75.6–85.6) to 81.6 mL/
min/1.73 m2 (95% CI, 76.5–86.7) in the protein group with no significant treatment x time 
interaction effect (P>0.05).
Dietary intake
Dietary intake data are presented in Table 4.4. Baseline habitual protein intake was 1.0 
(95% CI, 0.9–1.1) g/kg-bw/d and did not change over time in either group (P>0.05). When 
including the dietary protein supplements (i.e. 30 g/d), daily protein intake increased 
from 1.0 (95% CI, 0.9–1.1) to 1.3 (95% CI, 1.1–1.5) g/kg-bw/d in the protein group. Fat 
and carbohydrate intake did not differ between groups and remained similar over time. 
Habitual energy intake did not change significantly over time in either group (P>0.05).
Table 4.1 Baseline characteristics by treatment group
Variable Placebo (n=31) Protein (n=31)
Age, mean (SD), y 79 (6) 78 (9)
Women, No. (%) 21 (68) 20 (65)
Weight, mean (SD), kg 77.4 (13.2) 79.5 (15.6)
Height, mean (SD), m 1.66 (0.08) 1.66 (0.09)
BMI, mean (SD), kg/m2 28.2 (4.6) 28.7 (4.5)
MMSE, mean (SD), points 28.1 (1.8) 27.6 (1.8)
PCS12, mean (SD), points 42.8 (9.8) 42.6 (6.4)
MCS12, mean (SD), points 56.6 (8.2) 56.6 (7.2)
Glucose, mean (SD), mmol/L 5.2 (0.5) 5.4 (0.5)
Insulin, mean (SD), mU/L 18.1 (6.7) 19.6 (6.9)
eGFR, mean (SD), mL/min/1.73 m2 79.3 (19.9) 80.6 (14.1)
Systolic BP, mean (SD), mmHg 143 (20) 142 (19)
Diastolic BP, mean (SD), mmHg 73 (10) 74 (8) 
BMI: Body Mass Index. MMSE: Mini Mental State Examination. PCS12: Physical component score SF12. 
MCS12: Mental component score SF12. eGFR: estimated Glomerular Filtration Rate. BP: Blood pressure.
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Health status, blood pressure and cognitive function
Health status (SF-12 scores), blood pressure and cognitive function (MMSE) parameters 
did not differ between groups at baseline (Table 4.1) and did not change over time in 
either group (data not shown).
Discussion
The present study showed that 24 wks of resistance-type exercise training improved 
muscle strength and functional performance in frail elderly men and women. However, 
dietary protein supplementation was shown to be required during resistance-type exercise 
training to allow an increase in skeletal muscle mass in this frail elderly population.
A large number of potential participants were recruited and screened to allow inclusion 
of an adequate sample of frail elderly subjects (Figure 4.1). The latter resulted in the 
selection of 62 elderly subjects who met the defined frailty criteria37. These criteria 
have been reported to be highly predictive for falls, hospitalization, disability, and 
mortality37. Confirming their frailty, the selected subjects showed a low baseline physical 
performance38, poor leg25, and handgrip strength39 (Table 4.3).
Resistance-type exercise training has been established as an effective interventional 
strategy to counteract the age-related loss of muscle strength and performance in 
healthy and frail elderly people19,20,23-26. In agreement, we observed a substantial 43±4 and 
Figure 4.2 Intention to treat analysis on total lean body mass in the placebo and protein 
group (n=62). Data represent mean change in total lean mass after 12 and 24 wks relative to 
baseline (means ± SEM). P-value for treatment x time interaction = 0.006.
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37±3% increases in leg strength and 1.3±0.3 and 1.5±0.3 point improvements in physical 
performance (SPPB) in the placebo and protein supplemented group, respectively (Table 
4.3). The improvements in physical performance were mainly attributed to a decline in 
the time required to rise from a chair following 24 wks of training. These findings are 
consistent with previous results from shorter exercise training interventions among various 
elderly populations25,26 and translate to a reduced risk for disability38, institutionalization31, 
and mortality31. The subjects attended 83±2% of the scheduled training sessions and 
performed on average 65±1% of their 1-RM in 4 sets on the leg press and leg extension 
machines. The excellent adherence confirms the feasibility of such an intense, supervised 
resistance-type exercise training program for the frail elders. Government and healthcare 
workers should be stimulated to facilitate the implementation of resistance-type exercise 
training in such frail elderly population.
We provided a dietary protein supplement immediately after breakfast and lunch with 
the intention to further augment the skeletal muscle adaptive response to resistance-type 
exercise training. By supplementing 15 g protein twice daily, protein intake increased 
to more than 25 g with each main meal in the protein supplemented group40. In the 
placebo group, the subjects continued to ingest relative small amounts of dietary protein 
at breakfast (13 g) and lunch (20 g) during the entire intervention period (Table 4.4). It 
has been reported that these relative small amounts of protein are insufficient to allow 
a proper increase in post-prandial muscle protein synthesis rates in elderly subjects41, 
thereby compromising muscle mass maintenance. We hypothesized that increasing 
dietary protein intake at breakfast and lunch would stimulate muscle protein synthesis42 
and augment net muscle protein accretion during 24 wks of resistance-type exercise 
training. Confirming our hypothesis, we observed a significant 1.3±0.4 kg increase in 
lean body mass in the protein supplemented group. In contrast, no net increase in lean 
body mass was observed in the placebo group.
The muscle mass gain observed in the protein supplemented group entirely offset the 
decline in muscle mass that is generally reported in elderly people43,44. Instead of the annual 
loss of 0.5–1.0 kg muscle tissue42,43, we observed a net 1.3 kg increase in lean mass in the 
protein supplemented group. In the placebo group, the exercise intervention prevented a 
measurable decline in lean muscle mass, but in contrast to the protein group no net gain 
in lean mass was observed. Nonetheless, the preservation of muscle tissue will reduce 
the risk of developing chronic metabolic diseases such as obesity and type 2 diabetes45.
Despite a greater increase in muscle mass, protein supplementation did not further 
augment the increase in muscle strength and physical performance following 24 wks 
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of resistance-type exercise training. The latter is not surprising, as a disproportionate 
increase in muscle strength generally occurs during the first few months of resistance-
type exercise training. This increase in muscle strength was primarily attributed to 
changes in neuromuscular activation (i.e. motor unit recruitment) and/or increases in 
muscle quality46. The increase in skeletal muscle mass in the protein as opposed to the 
placebo supplemented group, will likely allow a further increase in muscle strength and 
performance as time progresses. This would translate in a greater training efficiency over 
a more prolonged training duration.
In the present study, we showed that dietary protein supplementation was required to 
gain muscle mass during prolonged exercise intervention in a frail elderly population. 
This protein supplementation (30 g/d) increased the habitual protein intake from 1.0 to 
1.4 g/kg-bw/d and did not result in a reduction in habitual energy intake (Table 4.4). 
Furthermore, the greater protein intake was not accompanied by any health complaints 
and also did not seem to affect renal function throughout the intervention period. Our 
present findings strongly advocate the ingestion of more protein during resistance-type 
exercise training in frail elderly people as a means to attenuate or even reverse the loss 
of muscle mass with aging and, as such, prevent the progression of frailty and functional 
decline.
We conclude that resistance-type exercise training represents an effective and feasible 
strategy to improve strength and physical performance in frail elderly people. Daily dietary 
protein supplementation (15 g protein, twice daily) is required to allow muscle mass 
gain during prolonged resistance-type exercise training in frail elderly men and women.
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Abstract 
Background: Although handgrip strength is considered a strong predictor of negative 
health outcomes, it is unclear whether handgrip strength represents a useful measure 
to evaluate changes in muscle strength following resistance-type exercise training in 
elderly people. 
Objective: To assess whether measuring handgrip strength provides proper insight in the 
efficacy of prolonged resistance-type exercise training to increase muscle mass, strength 
and physical performance in frail elderly people.
Design: Cross-sectional and prospective, parallel-group, intervention study.
Setting: University research center.
Participants: A total of 127 pre-frail and frail elderly people (≥65 y).
Measurements: Before, during, and after 24 wks of whole-body resistance-type exercise 
training handgrip strength (JAMAR), lean body mass (DXA), one-repetition maximum leg 
strength (1-RM), and physical performance (SPPB) were assessed in 127 frail elderly people.
Results: Handgrip strength correlated strongly with appendicular lean mass (r=0.68; 
P<0.001) and leg extension strength (r=0.70; P<0.001). After 24 wks of whole-body 
resistance-type exercise training, 1-RM leg extension strength improved significantly 
better when compared with the control group (from 57±2 to 78±3 kg vs 57±3 to 65±3 
kg: P<0.001). In agreement, SPPB improved significantly more in the exercise group 
(from 8.0±0.4 to 9.3±0.4 points) when compared with the control group (from 8.3±0.4 to 
8.9±0.4 points: P<0.05). These positive changes were not accompanied with any significant 
changes in handgrip strength (26.3±1.2 to 27.6±1.2 kg in the exercise group vs 26.6±1.2 
to 26.3±1.3 kg in the control group: P=0.71). 
Conclusion: Although handgrip strength strongly correlates with measures of muscle 
mass and leg strength in frail elderly people, handgrip strength does not provide a reliable 
means to evaluate the efficacy of exercise intervention programs to increase muscle mass 
or strength in an elderly population. 
87Validity of handgrip strength measure
5
Introduction 
Population demographics show that the number of elderly people aged 65 y and over will 
rise by approximately 50% over the next 30 years. This growth of the aging population 
is accompanied with an increased number of frail elderly people who are at risk of 
adverse health outcomes such as disability, co-morbidity and mortality. A dominant 
feature of frailty is the age-related loss of muscle mass and muscle strength, also called 
sarcopenia1,2. The latter is associated with physical impairment3,4, disability4,5 and loss 
of independence6. Interestingly, Goodpaster et al. showed that the decline in muscle 
strength occurs much more rapid than the concomitant loss of muscle mass7. Therefore, 
muscle strength has been identified as an important predictor for physical impairment, 
disability and institutionalization8. The importance of muscle strength for daily function 
necessitates the development of reliable and valid procedures to quantify muscle strength 
and evaluate the benefits of intervention programs.
There are numerous ways to assess muscle strength. A non-invasive, in-expensive and 
widely used measure to evaluate muscle strength is handgrip strength. This measure 
reflects the maximum isometric strength of the hand and forearm muscles, assessed 
with a dynamometer in a standing or sitting position. Ample epidemiological studies 
have shown that lower handgrip strength is strongly associated with health decline 
in elderly people, predominantly describing its association with physical disability9-16 
and mortality13,17. Although handgrip strength seems to represent a strong predictor 
of negative health outcomes, it is less clear whether handgrip strength correlates 
with measures of sarcopenia, such as muscle mass, leg muscle strength, and physical 
performance in frail elderly people.
Resistance-type exercise training has been shown to be a feasible and effective strategy to 
counteract sarcopenia. It has been well-established that resistance-type exercise training 
increases muscle mass and improves leg muscle strength in elderly people4,5,18. As such, 
resistance-type exercise training is now widely used to attenuate muscle mass loss, increase 
muscle strength and improve physical performance. As handgrip strength is non-invasive 
and an in-expensive assessment, we questioned whether measuring handgrip strength 
provides relevant insight in the efficacy of prolonged resistance-type exercise training to 
increase muscle mass, leg strength, and physical performance in an elderly population. 
We hypothesized that although handgrip strength strongly correlates with muscle mass, 
strength, and physical performance, handgrip strength does not respond to prolonged 
whole-body resistance-type exercise training in frail elderly people.
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Methods
Subjects
A total of 127 pre-frail and frail (according to the Fried criteria2) elderly subjects (≥65 
y) were included in the present study. Subjects who were diagnosed with any form of 
cancer, chronic obstructive pulmonary disease (COPD), diabetes (basal plasma glucose 
≥7 mmol/L)19, renal insufficiency (eGFR <60 mL/min/1.73 m2)20 were excluded from 
participation. None of the subjects had participated in a resistance-type exercise training 
program over the past 2 years. The inclusion of the elderly people and the design of 
the original studies are described in detail elsewhere21,22 as the present study is part of 
a larger project. This project investigated the impact of protein supplementation with 
or without a resistance-type exercise training program on muscle mass, strength and 
physical performance in frail elderly people. After inclusion, 127 subjects underwent 
the same series of measurements at baseline, after 12 and 24 wks (outlined below) to 
assess handgrip strength (JAMAR), muscle mass (DXA), leg strength (1-RM) and physical 
performance (SPPB)21,22. Sixty-two of these subjects were included in a 24 wk whole-
body resistance-type exercise training program (exercise group) and 65 subjects did 
not receive any exercise training (control group). The Wageningen University Medical 
Ethical Committee approved the studies and subjects gave their written informed 
consent.
Whole-body resistance-type exercise training program
Whole-body resistance-type exercise training was performed 2 times per wk under 
personal supervision for 24 wks. The sessions were performed in the morning and 
afternoon with at least 72 h between sessions. The training consisted of a 5 min 
warm-up on a cycle ergometer, followed by 4 sets on the leg press and leg extension 
machines and 3 sets on chest press, lat pulldown, pec-dec, and vertical row machines 
(Technogym, Rotterdam, the Netherlands). The workload started at 50% of 1-RM (10–15 
repetitions per set) and increased to 75% of 1-RM (8–10 repetitions per set) to stimulate 
muscle hypertrophy. Resting periods of 1 min were allowed between sets and 2 min 
between exercises. To evaluate changes in muscle strength, 1-RM was repeated after 4, 
8, 12, 16, and 20 wks of training. Workload intensity was adjusted based on the 1-RM 
outcomes.
89Validity of handgrip strength measure
5
Handgrip strength
Handgrip strength was measured using a hydraulic hand dynamometer (Jamar, Jackson, 
MI, USA). Three consecutive measures of dominant and non-dominant handgrip strength 
were recorded to the nearest 0.5 kg with subjects sitting in an upward position with the 
arm in a 90-degree angle position. The maximum strength effort was reported.
Body composition
Height was measured at baseline with a wall-mounted stadiometer to the nearest 0.1 
cm. Body weight was measured in the fasted state to the nearest 0.1 kg with a calibrated 
digital scale (ED-6-T; Berkel, Rotterdam, The Netherlands). In the fasted state, whole-
body, appendicular, and leg lean mass were measured by DXA (Lunar Prodigy Advance; 
GE Health Care, Madision, WI, USA).
Maximum leg strength 
Maximum leg strength was assessed by 1-RM strength tests on leg press and leg extension 
machines (Technogym, Rotterdam, the Netherlands). During a first familiarization session, 
the proper lifting technique was demonstrated and practiced, after which maximum 
strength was estimated using the multiple repetitions testing procedure for leg press 
and leg extension. In a second exercise session, 1 wk or more after the first strength 
estimation, the subjects’ 1-RM strength was determined21,22.
Physical performance
Physical performance was assessed with the short physical performance battery (SPPB) 
that comprised 3 components, i.e. standing balance, gait speed and chair stands23. Scores 
of 1 to 4 were based on categories of performance in the balance tests, on the time 
necessary to complete the walk, and on the time needed to perform the chair rise test. 
When subjects were unable to perform a test, a score of 0 was allocated. A summary 
SPPB score between 0 and 12 was obtained through summation of the scores obtained 
in the 3 individual tests.
Statistical analysis
Characteristics of the study population were reported as the mean ± standard deviation 
(SD), or as percentage. Independent sample T-tests for continuous variables and a Chi-
squared test for categorical variables were performed to compare participants from the 
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control and exercise group. Pearson’s correlation coefficients were calculated to assess the 
relation of baseline handgrip strength with lean mass, leg strength, physical performance 
and post intervention handgrip strength. Differences between treatments (exercise 
and control) over time were analyzed using mixed linear models with an unstructured 
covariance matrix. Time, treatment, and their interaction were defined as fixed factors and 
subject was defined as a random factor. Data analysis was performed by the intention to 
treat principle and all statistical analyses were performed using SPSS Statistics v19. An 
α-level of 0.05 was used to determine statistical significance.
Results
Between December 2009 and October 2010, 1420 elderly people were approached, 398 were 
screened and 127 participants were included into the studies. In total, 19 subjects withdrew 
from the studies, 8 from the control and 11 from the exercise trained group. For the intention 
to treat analyses, 8 dropouts, 4 in each group, were willing to have final assessments. 
The average adherence to the exercise protocol was 83±2%. Baseline characteristics are 
presented in Table 5.1 and showed no differences between groups (P>0.05).
Table 5.1 Characteristics of participants
Variable Total group
n=127
Control
n=65
Exercise
n=62
Age (y) 79.0±0.7 79.5±1.0 78.4±1.0
Women (%) 61 55 66
Height (m) 1.66±0.01 1.66±0.01 1.66±0.01
Weight (kg) 76.2±1.2 74.0±1.6a 78.5±1.8
Dominant handgrip strength (kg) 26.1±0.8 25.6±1.2 26.3±1.2a
Non-dominant handgrip strength (kg) 25.0±0.8 24.8±1.2 24.9±1.2a
Total lean mass (kg) 46.3±0.9 46.1±1.2b 46.1±1.2c
Appendicular lean mass (kg) 19.5±0.4 19.3±0.5b 19.3±0.5c
1-RM leg press (kg) 120±3 120±5d 120±4
1-RM leg extension (kg) 57±2 57±3e 57±2a
SPPB (points) 8.2±0.3 8.3±0.4b 8.0±0.4
Values are expressed as a mean±SEM or percentage. Superscript indicate missing values: a 1 missing 
value, b 4 missing values, c 6 missing values, d 16 missing values, e 17 missing values. There were no 
signifi cant differences between the control and exercise group (P>0.05).
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Figure 5.1 Baseline correlation between handgrip strength and appendicular lean mass in 
control (filled circles) and exercise (open circles) group (n=116). Handgrip strength correlated 
significantly with appendicular lean mass (r=0.68; P<0.001).
Figure 5.2 Baseline correlation between handgrip strength and leg extension strength in 
control (filled circles) and exercise (open circles) group (n=108). Handgrip strength correlated 
significantly with leg extension strength (r=0.69; P<0.001).
Chapter 592
Ta
bl
e 
5.
2 
Im
pa
ct
 o
f c
on
tr
ol
 a
nd
 e
xe
rc
is
e 
in
te
rv
en
tio
n 
on
 h
an
dg
rip
 s
tr
en
gt
h,
 le
an
 m
as
s, 
le
g 
st
re
ng
th
 a
nd
 p
hy
si
ca
l p
er
fo
rm
an
ce
Co
nt
ro
l
Ex
er
ci
se
Tr
ea
tm
en
t 
X 
tim
e
Tr
ea
tm
en
t 
ef
fe
ct
Ti
m
e 
ef
fe
ct
Va
ria
bl
e
0 
w
ks
12
 w
ks
24
 w
ks
0 
w
ks
12
 w
ks
24
 w
ks
D
om
in
an
t h
an
dg
rip
 s
tr
en
gt
h 
(k
g)
25
.6
±
1.
2
26
.1
±
1.
2
26
.3
±
1.
3
26
.3
±
1.
2
26
.9
±
1.
2
27
.6
±
1.
3
0.
71
0.
58
0.
04
N
on
-d
om
in
an
t h
an
dg
rip
 s
tr
en
gt
h 
(k
g)
24
.8
±
1.
2
25
.1
±
1.
2
25
.9
±
1.
2
24
.9
±
1.
2
25
.7
±
1.
3
26
.2
±
1.
2
0.
77
0.
81
0.
01
Le
an
 m
as
s 
(k
g)
a
46
.1
±
1.
2
46
.3
±
1.
2
46
.2
±
1.
2
46
.4
±
1.
2
47
.0
±
1.
2
46
.9
±
1.
2
0.
38
0.
74
0.
02
Ap
pe
nd
ic
ul
ar
 le
an
 m
as
s 
(k
g)
a
19
.3
±
0.
5
19
.4
±
0.
6
19
.4
±
0.
6
19
.7
±
0.
6
19
.8
±
0.
6
20
.0
±
0.
6
0.
21
0.
57
0.
05
1-
RM
 le
g 
pr
es
s 
st
re
ng
th
 (k
g)
b
12
0±
5
12
5±
6
13
7±
7
12
0±
4
15
1±
5
16
5±
6
0.
00
0.
02
0.
00
1-
RM
 le
g 
ex
te
ns
io
n 
st
re
ng
th
 (k
g)
b
57
±
3
61
±
3
65
±
3
57
±
2
72
±
3
78
±
3
0.
00
0.
62
0.
00
SP
PB
 (p
oi
nt
s)
c
8.
3±
0.
4
8.
5±
0.
4
8.
9±
0.
4
8.
0±
0.
4
8.
7±
0.
4
9.
3±
0.
4
0.
03
0.
90
0.
00
D
at
a 
re
pr
es
en
t m
ea
ns
±
SE
M
. I
nt
en
tio
n 
to
 tr
ea
t d
at
a 
w
er
e 
an
al
yz
ed
 u
si
ng
 a
 m
ix
ed
 li
ne
ar
 m
od
el
 (a
 n
=
11
8;
 b  
n=
11
2,
 c  
n=
12
3)
. 1
-R
M
: o
ne
-r
ep
et
iti
on
 m
ax
im
um
, 
SP
PB
: s
ho
rt
 p
hy
si
ca
l p
er
fo
rm
an
ce
 b
at
te
ry
.
93Validity of handgrip strength measure
5
Correlations
Handgrip strength of the dominant hand correlated with total lean mass (r=0.70; P<0.001) 
and appendicular lean mass (r=0.68; P<0.001, Figure 5.1). Furthermore, handgrip strength 
correlated with 1-RM leg press (r=0.59; P<0.001), and 1-RM leg extension strength (r=0.69; 
P<0.001: Figure 5.2). Handgrip strength correlated poorly with SPPB (r=0.23; P=0.10). 
Correlations of non-dominant handgrip strength and the above mentioned outcome 
measures were similar (data not shown).
Whole-body resistance-type exercise
The impact of whole-body resistance-type exercise training on handgrip strength, 
muscle mass, leg strength and physical performance are presented in Table 5.2. After 
24 wks, dominant handgrip strength had not changed significantly over time between 
the exercise (26.3±1.2 to 27.6±1.2) and control (25.6±1.2 to 26.3±1.3) group (P=0.71). 
However, a significant time effect was observed (P<0.05) indicating an increase in 
handgrip strength in both groups. Likewise for non-dominant handgrip strength, there 
was no significant treatment x time interaction (P=0.77), but a significant time effect 
Figure 5.3 Correlation between pre and post intervention handgrip strength (n=114). 
Pre intervention handgrip strength correlated significantly with post intervention handgrip 
strength (r=0.88; P<0.001).
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 (P<0.05). In line, a significant intraclass correlation coefficient (ICC) of 0.91 (P<0.05) and 
a significant correlation of handgrip strength prior and post exercise intervention (r=0.88; 
P<0.001: Figure 5.3) was observed. In contrast with handgrip strength, a significant time 
x treatment interaction was observed for leg extension strength (P<0.001). The increase 
in leg extension strength was significantly larger in the exercise group when compared 
with the control group (from 57±2 to 78±3 kg vs 57±3 to 65±3 kg; Figure 5.4). Likewise, 
Figure 5.4 Intention to treat analysis on dominant handgrip strength (A: n=127) and 1-RM 
leg extension strength (B: n=112) in the control (filled circles) and exercise group  (open circles). 
Data represents means±SEM. There was a no significant treatment x time interaction effect for 
the dominant handgrip strength (P=0.71), but significant treatment x time interaction effect 
for 1-RM leg extension strength (P<0.001).
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the increase in leg press strength was significantly larger in the exercise group when 
compared with the control group (P<0.001). In agreement, SPPB improved significantly 
more in the exercise group (from 8.0±0.4 to 9.3±0.4 points) when compared with the 
control group (from 8.3±0.4 to 8.9±0.4 points: P<0.05). 
Discussion
Prolonged whole-body resistance-type exercise training improves leg muscle strength 
and physical performance, but without measurable changes in handgrip strength even 
though handgrip strength correlates with appendicular lean mass and leg strength. Clearly, 
handgrip strength does not provide an appropriate means to evaluate the efficacy of an 
exercise intervention program to augment muscle mass, muscle strength, and/or physical 
performance in frail elderly people.
Handgrip strength is a non-invasive, in-expensive measurement and has been widely 
used in both clinical and epidemiologic settings. Although there is no clear consensus 
for the procedure of measurement of handgrip strength, a standardized protocol for 
measurements of handgrip strength has been established for older people which is based 
on the American Society of Hand Therapists (ASHT)24. The ASHT recommends subjects 
to be seated, with the shoulder adducted and elbow flexed at 90˚ and using a JAMAR 
dynamometer24 to perform the test. Using the latter standardized protocol, we show 
that handgrip strength strongly correlates with muscle mass (Figure 5.1) and strength 
(Figure 5.2) in a frail elderly population. A number of other studies have reported on 
similar associations between handgrip strength and functional ability in healthy elderly 
populations10-12, but none have studied the relation of handgrip strength with muscle 
mass, strength, and physical performance in a frail elderly population9-16. Our data support 
the general belief that handgrip strength can be used as a predictor for the progressive 
decline in muscle mass and strength with aging.
Using the JAMAR dynamometer, test–retest reliability of handgrip strength measurements 
has been confirmed in numerous studies, reporting intraclass correlation coefficient 
(ICC) values between 0.80–0.9825. Among community-dwelling elderly people, a more 
prolonged study reported an ICC of 0.95 for left handgrip strength and an ICC of 0.91 for 
right handgrip strength26. In agreement, we observed an ICC of 0.91 for both the dominant 
hand and non-dominant hand and a significant correlation of handgrip strength prior 
and post exercise intervention (Figure 5.3), confirming the reliability and reproducibility 
of the handgrip strength test in a frail elderly population.
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Even though handgrip strength seems to be a reliable, non-invasive, in-expensive 
measurement and a strong predictor for the progressive decline in muscle mass and 
leg strength, handgrip strength does not represent a valid measure to evaluate changes 
in muscle strength (Figure 5.4B) and physical performance (Table 5.2) in response to 
prolonged whole-body resistance-type exercise training programs. Prolonged whole-body 
resistance-type exercise training has been well-established as an effective interventional 
strategy to counteract the age-related loss of muscle strength and performance in healthy 
and frail elderly people27-32. A recent meta-analysis studying the impact of resistance-
type exercise training on muscle strength in elderly people showed a 29±2% increase 
in 1-RM leg press strength and a 33±2% increase in 1-RM leg extension strength33. In 
agreement, we observed a substantial 40±4% increase in leg press and 36±3% increase 
in leg extension strength following 24 wks of intervention. Importantly, the increase in 
leg muscle strength translated to a substantial 1.3±0.2 points improvement in physical 
performance as determined by the SPBB. Despite the whole-body resistance-type exercise 
program and the substantial improvements observed in leg muscle strength and physical 
performance, we failed to detect any significant changes in handgrip strength, even 
following 24 wks of resistance-type exercise training. Whereas some have reported minor 
increases in handgrip strength34-37, the majority of studies have not been able to detect 
significant changes in handgrip strength in response to traditional whole-body resistance-
type exercise training programs in elderly people38-45. Nonetheless, in such whole-body 
resistance-type exercise training programs, handgrip strength is often used as a parameter 
to assess overall muscle strength and/or functional improvements. The present study 
clearly shows that handgrip strength does not represent a clinically relevant and/or valid 
measure to evaluate changes in muscle strength and physical performance in response 
to prolonged whole-body resistance-type exercise training programs. The substantial 
increases in leg strength as much as 40% would have been overseen when only handgrip 
strength would have been selected as a parameter to evaluate the efficacy of a whole-
body exercise training program. Therefore, care should be taken when interpreting data 
on handgrip strength in relation to changes in muscle strength and function over time.
We conclude that although handgrip strength correlates well with measures of muscle 
mass and leg strength in frail elderly people, handgrip strength does not provide a reliable 
means to evaluate the efficacy of exercise intervention programs to increase muscle mass, 
strength, and/or improve physical performance in elderly people.
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Abstract 
Background/Objectives: Serum 25-hydroxyvitamin D (25(OH)D) status has been 
associated with muscle mass, strength and physical performance in healthy elderly 
people. Yet, in pre-frail and frail elderly people this association has not been studied. 
The objective of this study was to explore the association between vitamin D intake and 
serum 25(OH)D status with muscle mass, strength and physical performance in a pre-frail 
and frail elderly population. 
Subjects/Methods: This cross-sectional study included 127 pre-frail and frail elderly 
people in the Netherlands. Whole-body and appendicular lean mass (DXA), leg strength 
(1-RM), handgrip strength, and physical performance (SPPB) were measured and 
blood samples were collected for the assessment of serum 25(OH)D status (LC-MS/
MS). In addition, habitual dietary intake (3-d food records) and physical activity data 
(accelerometers) were collected. 
Results: In total, 53% of the participants had a serum 25(OH)D level below 50 nmol/L. After 
adjustment for confounding factors, 25(OH)D status was associated with appendicular 
lean mass (β=0.012, P=0.05), and with physical performance (β=0.020, P<0.05). Vitamin 
D intake was associated with physical performance (β=0.18, P<0.05), but not with 
appendicular lean mass (P>0.05). 
Conclusion: In this elderly population, 25(OH)D status is compromised and is associated 
with reduced appendicular lean mass and impaired physical performance. In addition, 
also vitamin D intake is associated with impaired physical performance. Our findings 
highlight the need for well-designed intervention trials to assess the impact of vitamin 
D supplementation on 25(OH)D status, muscle mass and physical performance in pre-
frail and frail elderly people. 
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Introduction 
Frailty is a geriatric syndrome of decreased reserves and resistance to stressors, which 
increases the risk for falls, disability, morbidity, and institutionalization1,2. An important 
and fundamental component of frailty is sarcopenia3. Sarcopenia is characterized by a 
progressive loss of skeletal muscle mass and physical performance4. The cause of this loss 
in muscle mass and performance is multifactorial and might include vitamin D deficiency5,6. 
The Institute of Medicine currently considers a serum 25(OH)D level below 50 nmol/L as 
being insufficient7. The estimated prevalence of vitamin D deficiency among healthy elderly 
people is between 45 and 57%8-10 and among compromised geriatric patients vitamin D 
deficiency is even more pronounced11,12. Compromised 25-hydroxyvitamin D (25(OH)D) 
status has been associated with poor muscle mass and impaired physical performance 
in community-dwelling elderly people5,6,13-15. Although significant associations between 
inadequate 25(OH)D status and reduced muscle mass, strength, and physical performance 
have been well-established in a healthy elderly population5,6,13-15, there are few data 
available on such associations in more compromised, frail elderly subpopulations. 
Studying the association between 25(OH)D level and muscle mass, strength and physical 
performance in a frail elderly population is important, since a compromised 25(OH)
D status might be more pronounced within this population together with decreased 
muscle mass, impaired physical performance16, and their risk for falls and fractures1,2. A 
compromised 25(OH)D status among frail elderly may predispose to the development 
of muscle mass loss and impairments in strength and physical performance resulting in 
more frequent falls and fractures17-20. Therefore, in the present study, we examined the 
association between 25(OH)D level and vitamin D intake with muscle mass, strength and 
physical performance in a pre-frail and frail elderly population.
Methods
Study sample
For two RCTs21,22, community-dwelling elderly participants, ≥65 y, were recruited between 
December 2009 and September 2010. Potentially eligible subjects were screened for 
pre-frailty and frailty using the Fried criteria2. These criteria were: [1] unintentional 
weight loss, [2] weakness, [3] self-reported exhaustion, [4] slow walking speed, and [5] 
low physical activity. Pre-frailty was classified when one or two criteria were present and 
frailty was defined when three or more criteria were present. Furthermore, subjects who 
were diagnosed with any form of cancer, chronic obstructive pulmonary disease (COPD), 
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diabetes type 1 and 2 (≥7 mmol/L)23, or renal insufficiency (eGFR <60 mL/min/1.73 m2)24 
were excluded. None of the subjects had participated in a resistance-type exercise program 
over the past 2 years. The baseline dataset of 127 pre-frail and frail elderly subjects was 
used for the current analysis. The Wageningen University Medical Ethical Committee 
approved the study and subjects gave their written informed consent.
Blood sampling and analysis 
After an overnight fast, blood samples were collected in EDTA-containing tubes and in 
serum tubes. The EDTA-containing tubes were centrifuged at 1000g at 4˚C for 10 min and 
serum tubes were centrifuged 90 min after the blood collection at 1000g at 20˚C for 15 
min. Aliquots of plasma and serum were snap frozen in liquid nitrogen and stored at -80˚C. 
The plasma samples were used to determine subjects’ glucose and insulin concentrations 
and the serum samples for creatinine and 25(OH)D concentrations. Plasma glucose 
concentrations were measured with a COBAS FARA analyzer (Uni Kit III; Roche, Basel, 
Switzerland). Insulin was measured by radioimmunoassay (Insulin RIA Kit; LINCO Research 
Inc, St Charles, MO, USA). Serum creatinine was measured by using Roche Modular System 
P (Roche Diagnostics GmbH, Mannheim, Germany). Serum 25(OH)D levels were measured 
using isotope dilution – online solid phase extraction liquid chromatography – tandem 
mass spectrometry (ID-XLC-MS/MS) by the Endocrine Laboratory of the VU University 
Medical Center, the Netherlands. 25(OH)D was released from its binding protein(s) and 
a deuterated internal standard (IS: 25(OH)D3-d6), was added. Samples were extracted 
and analyzed by XLC-MS/MS (a Symbiosis online SPE system; Spark Holland, Emmen, 
the Netherlands) coupled to a Quattro Premier XE tandem mass spectrometer (Waters 
Corp., Milford, MA, USA). The intra-assay and inter-assay coefficient of variance for this 
analysis were <6% and <8%, respectively, when using 3 concentrations between 25 and 
180 nmol/L and the Limit of Quantification was 4.0 nmol/L.
Dietary intake
Dietary intake data, including vitamin D intake, was obtained by means of 3-d food 
records. The 3 d of recording were randomly assigned to ensure that all days of the wk, 
including weekend days, were equally represented. Vitamin D supplement use was not 
assessed. Dietary data were coded (type of food, time of intake, and estimated portion 
size) and calculated using a food calculation system (BAS nutrition software 2004, Arnhem, 
The Netherlands) in which the Dutch food composition database of 2006 was included.
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Body composition, maximum strength and physical performance
Assessment of body composition, maximum strength and physical performance were 
performed within 4 wks following blood sampling. Lean body mass (LBM), appendicular 
lean mass (ALM), leg lean mass (LLM) and bone mineral content (BMC) were measured 
with Dual Energy X-ray Absorptiometry (DXA) scan (Lunar Prodigy Advance; GE Health 
Care, Madison, WI, USA). Maximum strength was assessed by one repetition maximum 
(1-RM) strength tests on leg press and leg extension machines (Technogym, Rotterdam, 
the Netherlands). During a familiarization session, the proper lifting technique was 
demonstrated and practiced, after which maximum strength was estimated. In a second 
session, ≥1 wk after the first strength estimation, the subjects’ 1-RM strength was 
determined25. Handgrip strength was measured using a hydraulic hand dynamometer 
(Jamar, Jackson, MI, USA). Three consecutive measures of handgrip strength (kg) exerted 
by both hands were recorded to the nearest 0.5 kg with subjects sitting in an upward 
position with the arm in a 90 degree angle. The maximum strength effort was reported. 
Physical performance was assessed with the short physical performance battery (SPPB) that 
comprised of 3 components i.e. standing balance, gait speed and chair stands26. Scores of 1 
to 4 were based on categories of performance in the balance tests, on the time necessary 
to complete the walk, and on the time needed to perform the chair rise test. When subjects 
were unable to perform a test, a score of 0 was allocated. A summary SPPB score between 
0 and 12 was obtained through summation of the scores obtained in the 3 individual tests.
Potential confounders
The following potential confounders were included in the statistical analysis: age, 
gender, height, body weight, alcohol (none, <1 consumption/d, >1 consumption/d), 
habitual physical activity, season of data collection, education (low, medium, high), 
serum creatinine, smoking, energy and protein intake. Height was measured with a wall-
mounted stadiometer and body weight with a calibrated digital scale (ED-6-T; Berkel, 
Rotterdam, the Netherlands). Habitual physical activity data were quantified using a tri-
axial accelerometer (ActiGraph GTX3, 2009, Pensacola, FL, USA) worn on the hip for 1 wk. 
Change of acceleration per second and epochs of 60 s were used. After 7 d, data were 
uploaded for analysis and analyzed using the MAH/UFFE analyzer, version 1.9.0.3 (MRC 
Epidemiology Unit, Cambridge, UK). Data files that did not meet 10 h of monitoring per 
day on at least 5 d as well as files that included periods of >100 min without activity were 
excluded from the analysis. Calcium intake was not included in the model because this 
did not change the β substantially.
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Statistics
Characteristics of the study population were reported as the mean ± standard deviation 
(SD), as percentage or as medians (25–75 percentile). Participants were grouped according 
to published 25(OH)D status cut points: <50 nmol/L and ≥50 nmol/L6,27. Chi-squared tests 
for categorical variables and independent sample T-tests for continuous variables were 
performed to compare participants with 25(OH)D levels below and above 50 nmol/L. 
Multiple linear regression analysis was used to investigate the association of 25(OH)D 
status and vitamin D intake with the outcome variables, adjusted for age, gender, height, 
body weight, alcohol, physical activity, education, smoking, creatinine (model 2) and 
energy and protein intake (model 3). Serum creatinine was not included as a confounder 
in any of the models investigating the association of vitamin D intake with the dependent 
variables. The statistical analysis was carried out using SPSS version 19 (SPSS, Chicago, 
IL, USA). A P-value ≤0.05 was considered as statistically significant.
Results
General characteristics of the study population are presented in Table 6.1. In total, 53% of 
the elderly in this study were vitamin D insufficient, as reflected by the number of persons 
with serum 25(OH)D levels below 50 nmol/L. In addition, 94% had a vitamin D intake below 
the estimated average requirement (EAR) of 10 μg/d7, with an average vitamin D intake of 
4.6±3.0 μg/d. Participants with sufficient 25(OH)D levels were more likely to be younger 
(P=0.01) and more physically active (P<0.001), compared to those with insufficient levels. 
Furthermore, crude data, as presented in Table 6.1, suggest better physical performance 
with higher serum 25(OH)D levels. Participants with 25(OH)D levels ≥50 nmol/L scored 
2 points higher on the SPPB when compared to participants with levels of 25(OH)D <50 
nmol/L (P<0.001). Analyzing the different components of the SPPB showed a similar trend. 
Gait speed and chair rise were performed significantly faster and also balance scores were 
higher among those with sufficient 25(OH)D levels, 4.8 vs. 6.3 s (P=0.01), 13.6 vs. 16.6 s 
(P=0.02) and 3.5 vs. 2.8 points on a 4 point scale (P=0.01), respectively. Vitamin D intake 
did not correlated with serum 25(OH)D levels, r=0.09 (P=0.30).
Associations between serum 25(OH)D status and vitamin D intake with measures of body 
composition are shown in Table 6.2. Serum 25(OH)D status appeared to be positively 
associated with ALM, β=0.012 (P=0.05) and showed a tendency for a positive association 
with LLM, β=0.009 (P=0.08). There was no association between vitamin D intake and 
measures of body composition.
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Table 6.1 Subject characteristics according to their 25(OH)D status
Variable Total sample
n=127
25(OH)D 
<50 nmol/L
n=67
25(OH)D 
≥50 nmol/L
n=60
P-value
25(OH)D (nmol/L)
(median ± lower/upper quartile)
47 (33–73) 35 (24–40) 73.5 (65–89.5) 0.00
Vitamin D intake (μg/d) 4.6±3.0 4.2±3.2 5.0±2.8 0.17
Age (y) 79.0±7.8 80.8±7.5 77.0±7.6 0.01
Women (%) 61 55 67 0.19
Weight (kg)a 76.2±13.8 77±14 75±14 0.38
Height (m) 1.66±0.09 1.66±0.09 1.66±0.09 0.86
BMI (kg/m2)a 27.5±4.3 27.8±4.3 27.2±4.4 0.55
Alcohol (%)
None
<1 consumption/ d
≥1 consumption/ d
28
32
40
30
34
36
25
31
44
0.67
Education level (%)
Low
Middle
High
5.5
59.6
34.6
6.0
61.2
32.8
5.0
58.3
36.7
0.89
Smoking (%)b 6.5 6.2 6.9 0.87
Total lean mass (kg)c 46.3±9.3 46.8±9.9 45.7±8.5 0.50
Appendicular lean mass (kg)c 19.5±4.3 19.7±4.7 19.3±3.9 0.32
Lean leg mass (kg)c 14.7±3.2 14.8±3.5 14.5±2.8 0.23
Fat mass (kg)c 26.2±9.0 26.5±8.8 25.9±9.2 0.69
Bone mineral content (kg)c 2.5±0.6 2.6±0.7 2.5±0.6 0.64
1-RM leg press (kg)d 120±34 120±35 120±34 0.99
1-RM leg extension (kg)e 57±19 57±19 58±19 0.85
Handgrip strength (kg)a 26.1±9.2 26.0±8.6 26.2±10.1 0.95
SPPB (points)b 8.2±2.8 7.1±2.9 9.2±2.3 0.00
Balance (points)b 3.1+1.1 2.8±1.3 3.5±0.8 0.01
Gait speed (sec)b 5.6±2.7 6.3±3.2 4.8±1.7 0.01
Chair rise (sec)f 15.1±6.2 16.6±6.0 13.6±6.0 0.02
Physical activity (counts/min)g 139.5±94.1 99.6±66.7 181±101 0.00
Energy intake (MJ/d)a 8.2±2.2 8.0±2.2 8.4±2.1 0.36
Calcium intake (mg) 1032±395 990±347 1078±440 0.21
Protein intake (g/d)a 76.4±21.6 75.8±20.6 77.0±22.9 0.75
Glucose (mmol/L)h 5.3±0.5 5.3±0.5 5.2±0.4 0.57
Insulin (mU/L)h 18.5±7.0 18.6±6.4 18.3±7.6 0.85
Creatinine (mmol/L) 72.8±14.8 75.0±14.4 70.4±13.8 0.07
Season (%)
Summer
Fall
48
52
52
48
43
57
0.32
Values are expressed as a mean ± SD, median with upper and lower quartile or percentage. Superscript 
indicate missing values: a 1 missing value, b 4 missing values, c 10 missing values, d 16 missing values, e 18 
missing values, f 28 missing values, g 21 missing values, h 17 missing values.
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Table 6.3 presents the associations of 25(OH)D status and vitamin D intakes with measures 
of maximum strength and physical performance. After full adjustment, significant 
associations were observed for 25(OH)D status and vitamin D intake with SPPB (β=0.020 
(P=0.035) and β=0.180 (P=0.038), respectively). 
Discussion
In total, 53% of the frail elderly had a compromised 25(OH)D status (<50 nmol/L). This 
compromised 25(OH)D status was associated with reduced appendicular lean mass 
and impaired physical performance. Low vitamin D intake was associated with impaired 
physical performance, but not with reduced appendicular lean mass.
The present study is the first cross sectional study investigating the association between 
25(OH)D status and muscle mass in a pre-frail and frail elderly population. To allow 
the inclusion of an adequate sample of frail elderly subjects, 1420 elderly people were 
approached, 398 were screened and finally 127 participants met the frailty criteria 
described by Fried et al.2. These criteria have been reported to be highly predictive for 
falls, hospitalization, disability, and mortality2. In agreement, the selected subjects were 
characterized by low baseline physical performance, strength and poor handgrip strength 
(Table 6.1). Moreover, this study revealed a high prevalence of elderly people with an 
insufficient 25(OH)D level. Since our blood sampling took place during summer and fall, 
this reported prevalence may be an underestimation of the 25(OH)D status for winter and 
early spring. During the winter and early spring, 25(OH)D levels have been reported to be 
substantially lower due to low sunlight exposure28, suggesting an even higher prevalence 
of frail elderly people with inadequate 25(OH)D levels.
In our study, a significant association between 25(OH)D status and ALM in a frail elderly 
population was found. This association of 25(OH)D status and ALM is supported by some5,6, 
but not all epidemiological studies29,30. Mechanistically, it is suggested that the activation 
of the vitamin D receptor (VDR) in skeletal muscle tissue plays an important role in the 
balance of muscle protein turnover31. The activation of the VDR might stimulate skeletal 
muscle protein synthesis31,32 and might prevent type 2 muscle fiber atrophy33. However, 
most work has been done in vitro and more research is needed in humans to understand 
the underlying mechanisms that support our findings on appendicular lean mass.
Our results indicated that 25(OH)D status and vitamin D intake are positively associated 
with physical performance measures in frail elderly people. We found that participants 
with 25(OH)D levels ≥50 nmol/L scored 2 points higher on the SPPB when compared to 
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participants with levels of 25(OH)D <50 nmol/L (P<0.001). In accordance, the SPPB score 
significantly improved with 0.02 points per 1 nmol/L increase in 25(OH)D and 0.18 points 
per 1 μg increase in vitamin D intake, indicating a clinically relevant improvement34. These 
findings are in line with the majority5,15,35-39, but not with all observational studies29,40. Our 
findings are in line with randomized, placebo-controlled trials, showing an improvement 
of physical performance after vitamin D supplementation in community-dwelling elderly 
people14,41,42. This improvement of physical performance might be attributed to the role 
of 1,25-dihydroxyvitamin D (1,25(OH)2D), the active form of 25(OH)D, in muscle. It has 
been suggested that 1,25(OH)2D regulates muscle calcium concentrations by modulating 
the activity of calcium pumps in sarcoplasmic reticulum and sarcolemma13. Alterations in 
intracellular calcium concentrations regulate the contraction and relaxation of muscle, which 
may impact physical performance. The latter underpins the importance of an adequate 
vitamin D intake and 25(OH)D status to improve or maintain physical performance.
A possible limitation might be the appearance of reverse causation due to the cross-
sectional design of the study. It may be that participants with the highest physical activity 
level and physical performance score are the ones that are the most likely to go outside 
and consequently have a higher 25(OH)D status, and not vice versa. However, a causal 
relationship seems plausible because of biologic mechanisms31 and evidence obtained 
from randomized, placebo-controlled trials33,42,43 that confirm the causality of 25(OH)D 
status and physical performance.
Despite the association of 25(OH)D status with appendicular lean mass, we found no 
significant association between vitamin D intake and appendicular lean mass. The latter 
finding might be explained by the lack of correlation between vitamin D intake and 25(OH)D 
status. In our study, vitamin D intake was 4.6±3.0 μg/d which is in line with our expectations 
as food fortification in the Netherlands is not broadly practiced and vitamin D rich products 
are often not part of the daily diet. The lack of association between vitamin D intake and 
25(OH)D status might be attributed by that low and narrow range of vitamin D intake. 
Despite the lack of correlation between vitamin D intake and 25(OH)D status in our study, 
a recent meta-regression analysis did show a significant association between vitamin D 
intake and 25(OH)D status44. Moreover, ample evidence presented an increase in 25(OH)D 
status after vitamin D supplementation12,45-47, suggesting that vitamin D supplementation 
represents an effective strategy to improve 25(OH)D status. Especially among frail elderly 
people there is a greater need to take a vitamin D supplements because endogenous vitamin 
D synthesis decreases with age. This deceased vitamin D synthesis might be explained by 
a low outdoor habitual physical activity48 and thus a low sunlight exposure as well as the 
reduced capacity to synthesize vitamin D in the skin49. More well-designed interventions 
Chapter 6114
studies are warranted to investigate the impact of vitamin D supplementation on 25(OH)D 
status and its impact on muscle mass and physical performance in a frail elderly population.
In conclusion, vitamin D deficiency is highly prevalent in a frail elderly population, which 
is associated with reduced ALM and impaired physical performance. In addition, also 
vitamin D intake is associated with impaired physical performance.
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The age-related loss of muscle mass and strength is currently recognized as one of 
the major determinants affecting physical frailty and disability. Lifestyle interventions 
that include physical activity and adequate nutrition might be promising strategies 
to attenuate or treat sarcopenia. In this thesis, we evaluated the daily protein intake 
of various elderly subpopulations, including that of frail elderly people. Based on this 
study, we designed intervention studies aiming to investigate the impact of protein 
supplementation with or without resistance-type exercise training on muscle mass, 
strength and physical performance in frail elderly people. These studies show that dietary 
protein supplementation did not increase muscle mass without a resistance-type exercise 
training program, but improved physical performance. Prolonged resistance-type exercise 
training improved strength and physical performance, but an adequate dietary protein 
is required to allow muscle mass gain during exercise training in frail elderly people. 
Dietary protein intake
It has been suggested that adequate dietary protein intake is required to attenuate 
and treat sarcopenia in elderly people. In chapter 3, we observed that dietary protein 
supplementation did improved physical performance in frail elderly people. These findings 
tend to be in line with the majority of studies showing that protein supplementation 
improves physical performance in (frail) elderly people (Table 7.1). However, intervention 
studies are limited, the heterogeneity among physical performance measures is high 
and the underlying mechanisms are unknown. Therefore, more research is warranted 
to study the impact of dietary protein supplementation on physical performance in 
the elderly. Although these data suggest that protein supplementation may improve 
physical performance in frail elderly people, simply increasing protein intake will not 
lead to substantial muscle mass gain (Table 7.1). So far, the most effective strategy to 
augment muscle mass and improve muscle strength and physical performance, is through 
stimulating physical activity.
Physical activity
Resistance-type exercise training is currently the most effective intervention to elicit 
improvements in muscle hypertrophy, muscle strength and physical performance14-19. 
Indeed, a recent meta-analysis, that included 49 studies, showed that after an average 
of 20.5 wks of resistance-type exercise training, elderly people gained 1.1 kg (CI: 0.9–1.2) 
lean body mass20. Furthermore, an additional meta-analysis showed that elderly people 
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improved 1-RM leg press strength by 29±2% and 1-RM leg extension strength by 33±2% 
after an average of 18 wks of resistance-type exercise training21. In agreement, we observed 
a substantial 40±4% increase in leg press and 36±3% increase in leg extension strength 
following 24 wks of intervention. Importantly, the increase in leg muscle strength translated 
to a substantial 1.3±0.2 points improvement in physical performance as determined by 
the SPBB. Despite, the benefits of resistance-type exercise training on muscle strength 
and physical performance, we failed to observe changes in muscle mass after 24 wks of 
exercise training without protein supplementation. It has been suggested that exercised 
muscles become more sensitive for nutrients, allowing more of the available amino acids 
to be synthesized into muscle protein. In sedentary elderly subjects, however, sensitivity of 
skeletal muscle tissue to anabolic stimuli such as physical activity might be reduced22,23. As 
such, it could be speculated that a more sedentary lifestyle is responsible for the anabolic 
resistance to physical activity and protein intake in frail elderly people22. In agreement, our 
frail elderly subjects had a sedentary lifestyle and we did not find a significant effect of 
resistance-type exercise training without protein supplementation on muscle mass. The 
combination of resistance-type exercise training and protein supplementation, however, 
did result in an increase in muscle mass, suggesting that dietary protein is required to 
overcome anabolic resistance in frail elderly people.
Dietary protein intake and physical activity
Dietary protein intake following a single bout of resistance-type exercise increases muscle 
protein synthesis rates and inhibits muscle protein breakdown, thereby allowing net muscle 
protein accretion24,25. As such, it is often suggested that dietary protein supplementation 
can maximize the skeletal muscle adaptive response to prolonged resistance-type exercise 
training. There has been much discrepancy in the literature on the proposed surplus 
benefits of dietary protein supplementation during prolonged resistance-type exercise 
training. Whereas some studies report greater gains in muscle mass and strength when 
dietary protein is supplemented during prolonged resistance-type exercise training26,27, 
most studies28-35 have failed to confirm these findings. In an attempt to explain the 
apparent discrepancy, Cermak et al. conducted a meta-analysis that investigated the 
impact of dietary protein supplementation during prolonged resistance-type exercise 
training in elderly people36. This meta-analysis, that included studies published prior to 
May, 2011, showed that dietary protein supplementation during ~12 wks of resistance-
type exercise training significantly resulted in a gain of 0.78 kg lean mass when compared 
with resistance-type exercise training without a protein based nutritional intervention36. 
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Notably, when studies were examined individually, only one study reported a statistical 
significant surplus benefit of protein supplementation during resistance-type exercise 
training on muscle mass gain when compared with a placebo. Though not statistically 
significant, the majority of studies, including the latest studies of Leenders et al.29, and 
Chale et al.35, did show a small effect of dietary protein supplementation on muscle mass 
during prolonged resistance-type exercise training. Although these small differences, i.e. 
0.78 kg lean mass, are not easily uncovered, over the course of many years these small 
differences may have a huge impact on muscle mass, strength, and physical performance. 
According to longitudinal studies in people aged 75 y or over37, muscle mass is lost at 
a rate of 0.64–0.98% per year. The latter reduction might be translated to an average 
0.3–0.5 kg loss of muscle mass for an average elderly individual (~50 kg lean mass). Our 
data show an increase of 1.2 kg lean mass after 12 wks and a total increase of 1.3 kg lean 
mass after 24 wks of intervention. When we extrapolate these data, one year of dietary 
protein supplementation and resistance-type exercise training would result in a further 
increase of some 0.2 kg lean body mass. Given the otherwise annual loss of 0.3–0.5 kg 
muscle mass, resistance-type exercise training and protein supplementation appear to 
prevent the age-related muscle loss and even augment muscle mass gain (i.e. 1.8–2.0 kg 
difference). In addition, muscle strength is lost more rapidly. At the age of 75 y, strength 
is lost at a rate of 3% per year37. We observed 30–40% increase in muscle strength after 
24 wks of intervention, which might be further improved over the course of many years. 
Although these data are highly speculative and long-term interventions, i.e. one to five 
years, are warranted, our data confirm the important role of adequate dietary protein 
ingestion and resistance-type exercise training to attenuate and even treat sarcopenia 
in the elderly. 
Dietary protein strategies to further augment muscle mass 
As resistance-type exercise training is currently the most effective intervention to stimulate 
muscle hypertrophy and as dietary protein further seems to stimulate these benefits, the 
combination of resistance-type exercise training and dietary protein supplementation 
is recommended as preferred approach to attenuate and/or treat sarcopenia. The small 
benefits of dietary co-intervention on the adaptive response to prolonged resistance-type 
exercise training might be enlarged by optimizing the dietary protein supplementation 
regimen. Various dietary protein intake strategies have been proposed, including the 
amount, timing and source of dietary protein. In addition, the population studied might 
be of importance to uncover the benefits of dietary protein.
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How much protein do we need
The recommended daily allowance (RDA) for protein for adults older than 18 y is 0.83 
g/kg-bw/d38, which is an estimate of the amount of protein necessary to avoid loss of 
lean body mass. Several experimental studies, however, suggest that the RDA for protein 
may not be adequate for older people to maintain skeletal muscle21. Accordingly, a daily 
protein intake between 1.2 and 1.5 g/kg-bw/d has been recommended to reduce the risk 
for adverse health outcomes, such as sarcopenia and frailty39-47. The latter is supported 
by data from our studies showing beneficial effects of protein supplementation in frail 
elderly people (chapter 3 and 4). Based on emerging evidence, we suggest that the 
RDA for protein for the elderly should be reconsidered. With a modification of the RDA 
for protein to 1.2–1.5 g/kg-bw/d, the protein intake of an average weighted individual 
(75 kg) would be 90–110 g per d. This amount of protein intake would allow to increase 
the protein intake of all main meals to 25–30 g, which showed to improve physical 
performance and supported the benefits of a resistance-type exercise training program 
in frail elderly people.
Timing of protein intake
Our observational data show that daily protein intake is not equally distributed over the 
various main meals, and that breakfast and lunch are particularly low in protein (chapter 
2). Interestingly, evidence suggests that the post-prandial muscle protein synthetic 
response to smaller, meal-like amounts of amino acids is attenuated in older subjects 
when compared with young controls23,48, resulting in a more negative net muscle protein 
balance and subsequent the degradation of muscle tissue. The attenuated muscle protein 
synthetic response to meal-like protein intakes will become of great clinical relevance over 
the course of many years. Consequently, it has been suggested that 25–30 g of dietary 
protein per main meal is required to allow an appropriate stimulation of post-prandial 
muscle protein synthesis and to overcome the attenuated protein synthetic response49-52 
and, as such, muscle mass accretion. In addition, ingesting ample protein prior to or 
post resistance-type exercise training has been shown to further improve post-exercise 
muscle protein synthesis53. In chapter 4, subjects consumed at least 25 g of protein 
prior to and post exercise training, allowing available amino acids to be synthesized 
into muscle protein, and as such, an 1.3±0.4 kg increase in muscle mass after 24 wks of 
intervention.
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What source of protein
An increase in essential amino acid (EAA) availability represents the main anabolic signal 
responsible for stimulating postprandial muscle protein synthesis rates54. Therefore, 
sources rich in EAA, i.e. milk, whey, casein, meat, egg, fish, as well as some vegetable 
protein sources, are potent in stimulating muscle protein synthesis in elderly people. 
However, the effect on postprandial muscle protein synthesis rates differs among these 
food sources, despite a relatively high proportion of EAA. Previous work suggests that 
ingestion of whey protein results in greater postprandial protein retention when compared 
with ingestion of casein51,55,56. The greater anabolic properties of whey versus casein 
protein have been attributed to the faster digestion and absorption kinetics of whey, 
resulting in a greater increase in postprandial plasma amino acid availability, thereby 
further stimulating muscle protein synthesis in elderly people51,55,57. Furthermore, whey 
protein has a high content of leucine, an essential amino acid. Earlier studies showed 
that a leucine-enriched mix of EAA increase muscle protein synthesis to a greater extent 
than other forms of protein58-60. Consequently, it is suggested that increasing the leucine 
content of a meal represents an effective strategy to enhance muscle hypertrophy in 
elderly people. In long-term intervention studies, however, we were unable to confirm 
that leucine co-ingestion with each main meal increases net muscle mass gain in elderly 
people8,13. These trials suggest that a complete mix of EAA, i.e. protein fractions or food 
products, is more likely to be beneficial than one single amino acid. Milk protein, i.e. 80% 
casein and 20% whey protein, is suggested to be a very potent protein source to stimulate 
muscle mass gain61. Previous studies showed that milk stimulated protein accretion to a 
greater extent than an isonitrogenous quantity of soy proteins62-64 did. In the presence 
of resistance-type exercise training, milk stimulated muscle protein synthesis65,66 and 
increased lean body mass in young subjects67,68. Our studies confirm these results in 
frail elderly people showing a significant increase in lean body mass after 24 wks of milk 
protein supplementation during prolonged resistance-type exercise training (chapter 4). 
Thus, dairy based proteins are very potent dietary protein sources to stimulate muscle 
synthesis and to enhance the benefits of resistance-type exercise training, and as such, 
elicit improvements in muscle hypertrophy in the elderly.
Population
The loss of muscle mass with aging is associated with a more sedentary lifestyle and 
a less than adequate dietary protein intake. Therefore, it could be speculated that the 
surplus benefits of dietary protein supplementation during prolonged resistance-type 
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exercise training are more evident in compromised frail elderly people. Though we can 
only speculate on the various factors that might explain the differences in the efficacy 
by which protein supplementation modulates the gain in muscle mass and physical 
performance between the healthy and frail elderly population, it might be that this 
disparity is attributed to differences in muscle mass, performance, inflammatory status, 
hormones, insulin resistance, the level of habitual physical activity, as well as dietary 
protein intake. Indeed, 21% of our population were sarcopenic69 and had significant 
lower muscle strength and physical performance scores compared with a healthy elderly 
population29. Consequently, the low muscle mass and impaired physical performance in 
frail elderly people would allow a window to reveal the surplus benefits of dietary protein 
supplementation during prolonged resistance-type exercise training. Furthermore, >90% 
of our frail elderly subjects had a sedentary lifestyle (Tieland et al., unpublished), which 
might reduce the sensitivity of skeletal muscle tissue to anabolic stimuli such as physical 
activity22,23. In fact, we observed no improvement in lean body mass in the placebo group, 
despite resistance-type exercise being a well-known intervention to augment muscle 
mass in healthy older adults20. Furthermore, frail elderly people tend to have higher 
plasma IL-6 and TNF-α concentrations70, lower testosterone levels71 and tend to be 
more insulin resistant72. It has been suggested that these factors play an important role 
in the anabolic resistance to physical activity and dietary intake in frail elderly people72. 
It could be speculated that the combination of an adequate dietary protein provision 
and resistance-type exercise training would allow frail elderly subjects to overcome the 
anabolic resistance, and as such, elicit improvements in muscle hypertrophy. Although, 
the latter hypothesis needs to be verified in more mechanistic studies, our data strongly 
support the benefits of dietary protein supplementation during resistance-type exercise 
training to augment muscle mass in a frail elderly population.
Future research strategies to augment muscle mass
As extensively discussed, dietary protein has been identified as the main dietary factor 
stimulating muscle protein synthesis and increasing muscle mass accretion during exercise 
training. However, other macronutrients may modulate the post-prandial muscle protein 
synthetic response to protein ingestion and therefore might play an important role in 
the development or treatment of sarcopenia and frailty.
Previous work suggests that carbohydrate co-ingestion with protein stimulates post-
prandial muscle protein synthesis rates73-78. This stimulation might be attributed to the 
greater post-prandial insulin release following carbohydrate co-ingestion. In agreement, 
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higher insulin concentrations have been reported to stimulate muscle protein synthesis 
rates when ample amino acids are available74. However, recent studies failed to observe 
surplus benefits of carbohydrate co-ingestion on post-prandial muscle protein synthetic 
response when ample protein is ingested in young77 and elderly subjects79,80. The 
latter results might be attributed to the population studied, since healthy subjects are 
generally not resistant to insulin. In frail elderly people, however, the high prevalence 
of insulin resistance might play an important role in the anabolic resistance to smaller, 
meal-like protein intakes. Therefore, it can be hypothesized that higher post-prandial 
insulin concentrations are required to maximize the muscle protein synthetic response 
to protein intake in a frail elderly population. Carbohydrate co-ingestion might induce 
greater post-prandial insulin release, allowing to overcome the anabolic resistance, and as 
such, stimulate the post-prandial muscle protein synthetic response to protein ingestion 
in frail elderly people.
Some evidence suggests that omega-3 fatty acids i.e. eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), are useful nutrients to prevent and/or treat sarcopenia. In 
cross-sectional studies, omega-3 fatty acids have been associated with leg strength81 and 
handgrip strength82 as well as with physical performance81,83. Furthermore, omega-3 fatty 
acids stimulated the post-prandial muscle protein synthetic response post amino acid and 
insulin infusion in older adults84. The latter muscle protein synthetic response is suggested 
to be mediated via increased activation of the mTOR pathway84. Furthermore, omega-3 
fatty acids have anti-inflammatory properties85, which may also help to overcome the 
anabolic resistance to physical activity and/or protein ingestion in older adults. Yet, the 
impact of omega-3 fatty acids on muscle metabolism are poorly understood and its long-
term effects on muscle mass and physical performance in elderly people are still unknown.
Vitamin D has been described as an important nutrient related to sarcopenia86-90. In 
chapter 6, we found that vitamin D status is compromised in frail elderly people. The 
25(OH)D status was associated with poor muscle mass and impaired physical performance. 
However, care should be taken interpreting these results since reverse causation might be 
apparent due to the cross-sectional design of the study. To investigate causality, several 
controlled intervention studies investigated the impact of vitamin D on muscle mass91,92, 
strength93 and physical performance93,91,94 in elderly people. A recent meta-analysis 
showed no beneficial effect of vitamin D treatment on handgrip strength, leg press 
and leg extension strength in community-dwelling elderly people93. In institutionalized 
elderly people that started with 25(OH)D status below 25 nmol/L, however, vitamin D 
supplementation did improve leg extension and proximal lower limb muscle strength91,94, 
suggesting that a more compromised elderly population might benefit from vitamin 
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D supplementation to enhance muscle strength. Although data from the latter studies 
present promising findings, evidence of the impact of vitamin D on muscle mass is scarce 
and present discrepant findings. This discrepancy is expected, given the different study 
populations, initial degrees of insufficiency, and doses of vitamin D and co-interventions 
tested. Therefore, randomized placebo-controlled trials are needed to elucidate the impact 
of vitamin D on the development of sarcopenia and frailty.
Though, carbohydrate, omega-fatty acids and vitamin D are all potential agents to 
augment muscle mass and physical performance, a combination of those nutrients 
embedded in a supplement or with the use of (enriched) foods might be most promising. 
A multi-nutrient supplement with at least 15 g of protein provided at breakfast and lunch 
during resistance-type exercise training in a compromised elderly population might be 
a very promising strategy to augment muscle mass and improve physical performance.
Public health implications
In a growing elderly population, the prevention or treatment of sarcopenia might reduce 
the risk for disability, dependence, institutionalization, hospitalization and mortality95-99. 
Our data clearly demonstrate that dietary protein supplementation and prolonged 
resistance-type exercise training augmented muscle mass and physical perform ance. 
Therefore, dietary protein and resistance-type exercise training play an important role 
in the prevention and/or treatment of sarcopenia. Other macronutrients and vitamin 
D might even further support the anabolic properties of dietary protein and exercise 
training, suggesting that sarcopenia is reversible with an adequate lifestyle intervention. 
The ability to treat sarcopenia not only reduces the estimated cost of sarcopenia36, but 
also decreases the risk of disability, dependence and frailty95-99. Furthermore, increasing 
muscle mass might reduce the risk for various diseases including diabetes and obesity38,98, 
increase survival during cancer treatments and accelerate post-operative recovery and 
subsequent hospital discharge. As such, our results and future research directions are 
not only important for the preservation and/or treatment of sarcopenia and frailty, but 
may have a much broader health impact. 
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Het aantal ouderen in de wereld neemt sterk toe. Vanaf 1950 tot 2000 is het aantal 
ouderen op de wereld verdrievoudigd tot 600 miljoen. Nu wordt het aantal ouderen op 
de wereld in 2050 zelfs geschat op 2 miljard. Het aantal Nederlanders boven de 65 in 
het jaar 2060 wordt nu op 25% van de totale bevolking geschat. Meer dan 40% van die 
ouderen zal dan 80 jaar of ouder zijn. Deze verwachte stijging van het aantal ouderen 
zal ook tot gevolg hebben dat meer ouderen fysieke beperkingen ondervinden bij het 
uitvoeren van hun dagelijkse activiteiten. Op dit moment heeft ongeveer 30% van de 
mensen boven de 55 jaar een fysieke beperking. Fysieke beperkingen kunnen gepaard 
gaan met verlies van eigen onafhankelijkheid, een verhoogde kans op opname in een 
verzorgingshuis, chronisch metabole ziekten en zelfs leiden tot vervroegd overlijden.
Het Ministerie van Volksgezondheid, Welzijn en Sport benadrukt dan ook het belang 
van preventie en adequate behandeling van ouderen met fysieke beperkingen, zodat zij 
zo lang mogelijk fysiek actief en onafhankelijk kunnen blijven en op die manier gezond 
ouder kunnen worden. 
Eén van de verklaringen voor het ontstaan van fysieke beperkingen gedurende het ouder 
worden is de progressieve afname van skeletspiermassa en spierkracht. Dit proces wordt 
ook wel sarcopenie genoemd. Sarcopenie gaat gepaard met een verminderde spierei-
witsynthese en een verhoogde spiereiwitafbraak, hetgeen resulteert in een negatieve 
spiereiwitbalans en afbraak van spiermassa. Factoren die hier mogelijk aan ten grondslag 
liggen zijn verhoogde inflammatie, veranderingen in hormoonspiegels, neurologische 
veranderingen, fysieke inactiviteit en inadequate voedselinname.
Om sarcopenie te voorkomen of tegen te gaan zijn krachttraining en een adequate 
eiwitinname belangrijk. Onderzoek wijst uit dat krachttraining de belangrijkste stimu-
lus is voor de spiereiwitsynthese. Inspanning verhoogt ook de spiereiwitafbraak, maar 
inspanning verhoogt de spiereiwitsynthese sterker dan de spiereiwitafbraak, waardoor 
een minder negatieve spiereiwitbalans ontstaat. Echter, zonder de inname van eiwitten 
blijft de balans tussen spiereiwitsynthese en spiereiwitafbraak negatief. Indien eiwitten 
worden ingenomen voor, tijdens of na een krachttraining wordt de balans wel positief 
en wordt er meer spier opgebouwd. 
Epidemiologisch onderzoek wijst uit dat de eiwitinname van gezonde ouderen zo rond 
de 1,1 gram per kg lichaamsgewicht per dag ligt. Bij fragiele ouderen ligt de inname iets 
lager en bij geïnstitutionaliseerde ouderen ligt de dagelijkse eiwitinname rond de 0,8 
gram per kg lichaamsgewicht per dag (hoofdstuk 2). We hebben ook de eiwitinname 
per maaltijdmoment bestudeerd. Bij fragiele ouderen bedraagt de eiwitinname bij het 
ontbijt gemiddeld 11 gram en bij de lunch 16 gram. Dit lijkt onvoldoende te zijn voor een 
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maximale spiereiwitsynthese. Eerder onderzoek toont aan dat bij een eiwitinname van 
15–20 gram de eiwitsynthese bij ouderen significant lager is dan bij jongere deelnemers. 
Er wordt gesuggereerd dat minimaal 25 gram eiwit per hoofdmaaltijd nodig is voor een 
meetbare toename in spiereiwitsynthese na een maaltijd. Uitgaande van het gegeven 
dat fragiele ouderen een (te) lage eiwitinname hebben bij het ontbijt en bij de lunch en 
het feit dat er nog maar weinig onderzoek is gedaan in deze ouderenpopulatie zijn we 
twee lange-termijn-interventiestudies gestart. 
De eerste interventiestudie staat beschreven in hoofdstuk 3. In deze studie zijn de effecten 
van 24 weken eiwitsuppletie op spiermassa, spierkracht en fysiek functioneren van 65 
fragiele ouderen onderzocht. De deelnemers hebben 24 weken lang twee keer per dag, bij 
het ontbijt en bij de lunch, een supplement met 15 gram eiwit of een placebosupplement 
gekregen. Na 24 weken interventie is de hoeveelheid spiermassa in beide groepen gelijk 
gebleven. Wel is het fysiek functioneren na 24 weken eiwitsuppletie significant verbeterd 
(P<0,05). In de controlegroep daarentegen is het fysiek functioneren onveranderd ge-
bleven. We concluderen dat extra eiwitinname bij het ontbijt en bij de lunch het fysiek 
functioneren van fragiele ouderen significant verbetert.
De tweede interventiestudie staat beschreven in hoofdstuk 4. In deze studie zijn ge-
durende 24 weken de effecten van eiwitsuppletie én krachttraining op spiermassa, 
spierkracht en fysiek functioneren van 62 fragiele ouderen bestudeerd. De deelnemers 
hebben 24 weken lang twee keer per dag, bij het ontbijt en bij de lunch, een supplement 
met 15 gram eiwit of een placebosupplement gekregen. Zowel in de eiwitgroep als in de 
placebogroep hebben de deelnemers een krachttrainingsprogramma gevolgd. In zowel 
de eiwitgroep als in de placebogroep zijn spierkracht en fysiek functioneren significant 
toegenomen. Zo is de spierkracht na 24 weken met 40% toegenomen in beide groepen. 
Eiwitsuppletie is echter nodig om de spiermassa te doen vergroten. Na 24 weken kracht-
training en eiwitsuppletie is de spiermassa met 1,3 kg significant toegenomen (P<0,05). 
In de controle groep daarentegen, is de hoeveelheid spiermassa onveranderd gebleven. 
Naast deze twee interventiestudies is in hoofdstuk 5 de relatie tussen handknijpkracht en 
beenspierkracht en de impact van krachttraining op handknijpkracht van fragiele ouderen 
bestudeerd. Uit ons onderzoek is handknijpkracht geen goede maat gebleken om de 
lange-termijneffecten van krachttraining op spierkracht te meten bij oudere deelnemers.
In hoofdstuk 6 is de relatie tussen vitamine D status en spiermassa, kracht en fysiek func-
tioneren bestudeerd bij fragiele ouderen. In deze observationele studie hebben wij een 
relatie tussen een lage vitamine D status en een verminderd fysiek functioneren gevonden. 
Ook is een verband tussen een lage vitamine D inname en een verminderd fysiek func-
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tioneren aangetoond. Onze studie suggereert dat vitamine D een belangrijke rol speelt 
bij het fysiek functioneren van fragiele ouderen. Er zijn echter meer interventiestudies 
nodig om de impact van vitamine D op de spierfunctie van fragiele ouderen aan te tonen.
Onze bevindingen kunnen mogelijk een grote impact hebben op de gezondheid en 
kwaliteit van leven van ouderen. Ondanks dat eiwitsuppletie de spiermassa niet vergroot, 
lijkt eiwitsuppletie wel een veelbelovende strategie te zijn om fysiek functioneren van 
fragiele ouderen te verbeteren. Daarnaast toont dit proefschrift duidelijk aan dat langdu-
rige krachttraining een effectieve methode is om spierkracht en fysiek functioneren van 
fragiele ouderen te verbeteren. Op basis van onze bevindingen is hierbij extra eiwitinname 
nodig om de spiermassa van fragiele ouderen te vergroten. Langdurige krachttraining 
en eiwitsuppletie kunnen een belangrijke bijdrage leveren om sarcopenie te beperken 
en wellicht ook te voorkomen. 
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